Document:

EX-4.2

Exhibit 4.2

THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF

1933, AS AMENDED, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION

WITH, THE SALE OR DISTRIBUTION THEREOF. SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED

OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT THEREUNDER OR AN EXEMPTION

FROM SUCH REGISTRATION

MARKETAXESS HOLDINGS INC.

WARRANT

TO PURCHASE COMMON STOCK

			
	Certificate Number: ___
	 	Dated:      , 2008

          For value received, [TCV VI, L.P. / TCV Member Fund, L.P.] (the “Investor”), is entitled to
purchase from MarketAxess Holdings Inc., a Delaware corporation (together with its successors and
assigns, the “Company”), at any time and from time to time after the date set forth above and prior
to 5:00 p.m., New York time, on the Expiration Date (as defined in Section 1.1 below), at the
purchase price of $10.00 per share (as such price may be adjusted pursuant to Section 2, the
“Exercise Price”) an aggregate of ___ fully-paid and nonassessable shares of the Company’s
voting common stock, par value $0.003 per share (“Common Stock”) (as such shares may be adjusted
pursuant to Section 2 below, the “Warrant Shares”). Certain terms used but not defined elsewhere
herein have the meanings assigned to them in Section 16 below.

          This Warrant (“Warrant”) is being issued to the holder in accordance with a Securities
Purchase Agreement of even date herewith (the “Purchase Agreement”) by and among the Company, the
Investor and [TCV VI, L.P / TCV Member Fund, L.P.].

     Section 1. Term and Exercise of Warrant.

          1.1 Term of Warrant. The holder shall have the right, at any time before 5:00 p.m.,
New York time, on the tenth anniversary of the date hereof, or, if such date is not a Business Day,
the next Business Day (the “Expiration Date”) to exercise this Warrant in accordance with the terms
hereof.

          1.2 Exercise of Warrant.

               (a) Cash Exercise. This Warrant may be exercised at any time prior to the Expiration
Date and from time to time, in whole or in part, upon surrender to the Company, in care of the
Secretary of the Company, together with the duly completed and signed form of

 

 

Notice of Exercise (designating thereon the holder’s election to Cash Exercise) in the form
attached hereto (the “Exercise Notice”), and payment to the Company of the Exercise Price in effect
on the date of such exercise for the number of Warrant Shares in respect of which this Warrant is
then being exercised. Payment of the aggregate Exercise Price upon exercise pursuant to this
Section 1.2(a) shall be made by delivery of a good check to the principal executive offices of the
Company or, at the holder’s discretion, by wire transfer of immediately available funds in
accordance with written wire transfer instructions to be provided by the Company at the holder’s
request.

               (b) Net-Issue Exercise. In lieu of exercising the Warrant on a cash basis pursuant to
Section 1.2(a), the holder may elect to exercise the Warrant at any time prior to the Expiration
Date and from time to time, in whole or in part, on a net-issue basis by electing to receive the
number of Warrant Shares which are equal in value to the value of this Warrant (or any portion
thereof to be canceled in connection with such net-issue exercise) at the time of any such
net-issue exercise, by surrender of the Warrant, together with the duly completed and signed
Exercise Notice (designating the holder’s election to Net-Issue Exercise), to the Company, in care
of the Secretary of the Company at the principal executive offices of the Company; provided that
the holder may not elect to exercise the Warrant on a net-issue basis if at such time the holder
would be prohibited from transferring the Warrant Shares pursuant to Section 2(a) of the Investor
Rights Agreement. The Exercise Notice shall be properly marked to indicate (A) the number of
Warrant Shares to be delivered to the holder in connection with such net-issue exercise, (B) the
number of Warrant Shares in respect of which the Warrant is being surrendered in payment of the
aggregate Exercise Price for the Warrant Shares to be delivered to the holder in connection with
such net-issue exercise, calculated as of the Determination Date (as defined below) and (C) the
number of Warrant Shares which remain subject to the Warrant after such net-issue exercise, if any
(each as determined in accordance with this Section 1.2(b)). In the event that the holder elects
to exercise the Warrant in whole or in part on a net-issue basis pursuant to this Section 1.2(b),
the Company will issue to the holder the number of Warrant Shares determined in accordance with the
following formula:

X = Y (A-B) / A

where:

	 	•	 	“X” is the number of Warrant Shares to be issued to the holder in connection with such
net-issue exercise;
	 
	 	•	 	“Y” is the number of Warrant Shares to be exercised, up to the number of Warrant Shares
subject to this Warrant;
	 
	 	•	 	“A” is the Fair Market Value as of the Determination Date of one share of Common Stock;
and
	 
	 	•	 	“B” is the Exercise Price in effect as of the date of such net-issue exercise (as
adjusted pursuant to Section 2.1 below). 

-2-

 

For purposes of this Section 1.2(b), the “Fair Market Value” of one share of Common Stock will have
the following meanings: (i) if the Common Stock is listed for trading on a national securities
exchange or admitted for trading on a national market or other quotation system, then the Fair
Market Value of one share of Common Stock will be deemed to be the closing sales price quoted on
the principal securities exchange on which the Common Stock is listed for trading, or if not so
listed, the average of the closing bid and asked prices for the Common Stock quoted on the national
market or other quotation system on which Common Stock is admitted for trading, each as published
in The Wall Street Journal (western edition) (or, if such prices are not published in The Wall
Street Journal (western edition), as reported by the applicable authority or association governing
trading of the Common Stock) (the “Closing Sales Price”), in each case for the ten (10) Trading
Days immediately preceding, but not including the Determination Date; or (ii) if the Common Stock
is not listed for trading on a national securities exchange or admitted for trading on a national
market or other quotation system, then the Fair Market Value of one share of Common Stock will be
deemed to be the fair market value of the Common Stock as determined in good faith from time to
time by the Company’s board of director’s (the “Board of Directors”) as of the Determination Date,
and receipt and acknowledgment of this Warrant by the holder will be deemed to be an acknowledgment
and acceptance of any such determination by the Board of Directors as the final and binding
determination of such Fair Market Value for purposes of this Section 1.2(b). The “Determination
Date” of Fair Market Value will be the date indicated on the Exercise Notice; provided, however,
that if the Company does not receive the Exercise Notice within five (5) business days of the date
indicated thereon, the Determination Date will be the date the Company receives such Exercise
Notice.

               (c) Fractional Interests. No fractional shares of Common Stock shall be issued upon
the exercise of the Warrant, but in lieu thereof the Company shall pay therefor in cash an amount
equal to the product obtained by multiplying the Closing Sales Price of one share of Common Stock
(or if the Common Stock is not listed for trading on a national securities exchange or admitted for
trading on a national market or quotation system, then the Fair Market Value of the Common Stock as
determined by the Board of Directors in the manner set forth in clause (ii) of the penultimate
sentence of Section 2.2(b)) on the Trading Day immediately preceding the date of exercise of the
Warrant times such fraction (rounded to the nearest cent).

               (d) Deemed Issuance. Subject to 1.2(c) hereof, upon such surrender of the Warrant,
delivery of the Exercise Notice and, in the case of a cash exercise pursuant to Section 1.2(a),
payment of the Exercise Price, the Company shall, subject to the last sentence of this Section
1.2(d), issue and cause to be delivered with all reasonable dispatch (and in no event more than
three Business Days from delivery of the Exercise Notice) to and in the name of the holder, or in
the name of such other person as designated by the holder, a certificate or certificates for the
number of full shares of Common Stock so purchased upon the exercise of the Warrant, together with
a check or cash in respect of any fraction of a share of Common Stock otherwise deliverable upon
such exercise, as provided in Section 1.2(c). Such certificate or certificates shall be deemed to
have been issued, and the person in whose name any such certificates will be issuable upon exercise
of this Warrant (as indicated in the applicable Election Notice) shall be deemed to have become a
holder of record of such Warrant Shares as of the date of the surrender of the Warrant and, in the
case of a cash exercise pursuant to Section 1.2(a), payment of the Exercise Price. Notwithstanding
the foregoing, if HSR Clearance or FSA Approval is required in connection with the exercise of the
Warrant, as indicated by the holder

-3-

 

on the applicable Election Notice delivered to the Company in accordance with this Section
1.2, the Warrant Shares purchased upon exercise of the Warrant and the check or cash in respect of
any fractional shares of Common Stock shall not be issued, and such holder shall not be deemed to
have become a holder of record of such Warrant Shares, until the date upon which the holder has
notified the Company in writing that such holder has obtained HSR Clearance or FSA Approval, as
applicable, with respect to such exercise has occurred. The holder shall use his, her or its
reasonable best efforts to obtain HSR Clearance or FSA Approval, if required, and shall keep the
Company informed of the status thereof.

               (e) Warrant Exercisable in Whole or in Part. The rights of purchase represented by
the Warrant shall be exercisable, at the election of the holder, either in full or from time to
time in part. If the Warrant is exercised in respect of less than all of the Warrant Shares
purchasable on such exercise at any time prior to the Expiration Date, a new Warrant of like tenor
exercisable for the remaining Warrant Shares may be issued and delivered to the holder by the
Company. The Warrant or any part thereof surrendered in the exercise of the rights thereby
evidenced shall thereupon be cancelled by the Company and retired.

     Section 2. Adjustment of Exercise Price and Warrant Shares.

          2.1 Mechanical Adjustments. The Warrant Shares purchasable upon the exercise of the
Warrant and the Exercise Price therefore shall be subject to adjustment from time to time as
follows:

               (a) Stock Splits, Combinations and Dividends. If the Company shall at any time, and
from time to time, pay a dividend on its shares of Common Stock in shares of Common Stock,
subdivide or split its outstanding Common Stock into a larger number of shares or combine or
consolidate its outstanding Common Stock into a smaller number of shares, then, in each such case,
the number of Warrant Shares thereafter issuable upon exercise of this Warrant shall be adjusted so
that this Warrant shall thereafter be exercisable for the number of shares of Common Stock equal to
the number of shares of Common Stock which the holder would have held after the occurrence of any
of the events described above had this Warrant been exercised in full immediately prior to the
occurrence of such event. An adjustment made pursuant to this Section 3.1(a) shall become
effective retroactively to the related record date in the case of a dividend and shall become
effective on the related effective date in the case of a subdivision, split, combination or
consolidation. The provisions of this Section 2.1(a) will apply with equal force and effect to all
successive dividends, subdivision or splits.

               (b) Reclassifications. In the event of a reclassification of the Common Stock other
than by stock split, subdivision, consolidation or combination thereof, the Company will execute a
new Warrant, the terms of which provide that the holder of this Warrant will have the right to
exercise the rights represented by such new Warrant, and procure upon such exercise in accordance
with the terms of this Warrant, in lieu of the shares of Common Stock previously issuable upon
exercise of the rights represented by this Warrant, the kind and amount of stock, other securities,
property, cash or other assets receivable upon such reclassification by a holder of an equivalent
number of shares of Common Stock at the time of such reclassification. Such new Warrant will
provide for adjustments which are as equivalent as practicable to the adjustments

-4-

 

 provided for in this Section 2.1 The provisions of this Section 2.1(b) will apply with
equal force and effect to all successive reclassifications of the Common Stock.

               (c) Merger or Consolidation. If at any time there will be effected a merger or
consolidation of the Company with or into another person, or a sale of all or substantially of the
Company’s assets, or all or substantially all of the assets of the Company’s Subsidiaries, in such
way that holders of Common Stock will be entitled to receive in connection with such transactions,
stock, securities, property, cash or other assets with respect to or in exchange for their shares
of Common Stock, then, as a part of such merger, consolidation or sale, lawful appropriate
provision will be made so that the holder after such merger, consolidation or sale will be entitled
to receive upon exercise of its rights to purchase the Warrant Shares, the number of shares of
stock or other securities or property, cash or other assets equivalent to that which a holder of
the number of shares of Common Stock deliverable upon exercise of this Warrant in full pursuant to
Section 1.2(a) immediately prior to such transaction would have been entitled to receive in
connection with such merger, consolidation or sale. If the holders of shares of Common Stock are
entitled to make an election with respect to the type, kind or amount of securities, property, cash
or other assets they are to receive in connection with such merger, consolidation or sale, then for
purposes of determining the type and number of shares of stock or other securities or property,
cash or other assets issuable upon exercise of this Warrant, the holder of this Warrant shall
notify the Company, or its successor or the acquior, by the time the holders of shares of Common
Stock are allowed to make such election, as to which election such holder makes. If the holder of
this Warrant does not notify the Company, or its successor or the acquior, within such time,
then the holder will be treated as if it had chosen to be treated the same as a holder of shares of
Common Stock who failed to make the election in connection with the merger, consolidation or sale.
In any such case, appropriate adjustment (as determined in good faith by the Board of Directors)
will be made in the application of the provisions of this Warrant with respect to the rights and
interests of the holder after the merger, consolidation or sale to the end that the provisions of
this Warrant (including adjustments of the Exercise Price and number and type of securities
purchasable pursuant to the terms and conditions of this Warrant) will be applicable after the
transaction, as near as reasonably may be, in relation to any stock or other securities or
property, cash or other assets deliverable after that transaction upon the exercise of the holder’s
rights to purchase the Warrant Shares. The Company will not effect any such merger, consolidation
or sale unless, prior to the consummation thereof, each person (other than the Company) that may be
required to deliver any stock, other securities, property, cash or other assets upon the exercise
of this Warrant as provided herein shall assume (but such assumption shall not release the Company
of its obligations under this Warrant), by written instrument delivered to the holder of this
Warrant, the obligations of the Company under this Warrant, including the obligation to deliver to
the holder such stock, other securities, property, cash or other assets a such holder may be
entitled to receive in accordance with this Section 2.1(c). The provisions of this Section 2.1(c)
will apply with equal force and effect to all successive merger, consolidations and sales. If,
after taking into account and as a result of the provisions of this Section 2.1(c), the Warrant is
only exercisable for cash, and the cash consideration to be received by holders of the Warrant upon
exercise in full pursuant to Section 1.2(a) is less than the aggregate Exercise Price, this Warrant
shall terminate and be of no further force or effect.

-5-

 

               (d) Whenever the number of Warrant Shares issuable upon the exercise of this Warrant is
adjusted or readjusted pursuant to Section 2.1, the Exercise Price payable upon exercise of this
Warrant shall be adjusted or readjusted by multiplying such Exercise Price in effect immediately
prior to such adjustment by a fraction, the numerator of which shall be the number of Warrant
Shares purchasable upon the exercise of this Warrant immediately preceding such adjustment, and the
denominator of which shall be the number of Warrant Shares so purchasable immediately thereafter.
All calculations under this Section 2 shall be made to the nearest one-thousandth of a share of
Common Stock.

               (e) In the event that at any time, as a result of an adjustment made pursuant to this Section
2.1, the holder shall become entitled to receive any securities or property other than shares of
Common Stock, thereafter (i) the number of such other securities or property so receivable upon
exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time in
a manner and on terms as nearly equivalent as practicable to the provisions with respect to the
Common Stock contained in this Section 2.1, and the provisions of Sections 2.2, 2.3, 2.4 and 2.5,
inclusive, with respect to the Warrant Shares, shall apply on like terms to any such other
securities and property, and (ii) the term “Common Stock” shall mean, to the extent the context
indicates, the type or class other securities or property issuable upon exercise of this Warrant.

          2.2 Time of Adjustments. Except as otherwise expressly provided in Section 2.1, each
adjustment required by Section 2.1 shall be effective as and when the event requiring such
adjustment occurs.

          2.3 Notice of Adjustment. Whenever the Warrant Shares purchasable upon the exercise
of the Warrant or the Exercise Price is adjusted as herein provided, the Company shall as soon as
practicable mail by first class mail, postage prepaid, to the holder, a certificate of an officer
of the Company setting forth the number of Warrant Shares (or other stock, securities or property,
cash or other assets) purchasable upon the exercise of the Warrant and the Exercise Price after
such adjustment, setting forth a brief statement of the facts requiring such adjustment and setting
forth the computation by which such adjustment was made.

          2.4 No Adjustment for Cash Dividends. Except as provided in Section 2.1, no
adjustment shall be made with respect to this Warrant or upon the exercise of this Warrant in
respect of any cash dividends declared or paid on the Common Stock.

          2.5 Statement on Warrant. Irrespective of any adjustments in the Exercise Price or
the number or kind of stock, other securities, property, cash or other assets purchasable upon the
exercise of the Warrant, any Warrant theretofore or thereafter issued may continue to express the
same Exercise Price and number and kind of shares issuable upon exercise of this Warrant as are
stated in the initial Warrant.

     Section 3. Transfer of Warrant. Subject to the provisions of the Investor Rights
Agreement, this Warrant and the rights represented hereby may be transferred in whole or in part by
the holder. In order to effect any transfer or partial transfer of this Warrant, the holder hereof
shall deliver this Warrant to the Company with the Notice of Transfer in the form attached hereto
completed and duly executed. Upon receipt of Notice of Transfer, the Company shall promptly

-6-

 

(i) issue to the transferee a new Warrant for the number of Warrant Shares assigned by the
holder of the Warrant, and (ii) to the extent the transfer contemplated by the Notice of Transfer
is not for the entire number of Warrant Shares represented by this Warrant, issue to the holder a
replacement Warrant representing the balance of such Warrant.

     Section 4. Taxes. The issuance of certificates for Warrant Shares upon the exercise
of the rights represented by this Warrant will be made without charge to the holder of this Warrant
for any issuance tax in respect thereof; provided, however, that the Company shall not be required
to pay any tax which may be payable in respect of any transfer involved in the issuance and
delivery of any certificate in a name other than that of the holder of this Warrant.

     Section 5. Representations and Warranties of the Company. The Company hereby
represents and warrants to the holder of the Warrant:

          5.1 Authorization. The Warrant has been duly authorized and validly executed and
delivered by the Company and constitutes a valid and legally binding obligation of the Company
enforceable against the Company in accordance with its terms, except as enforceability may be
limited by bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other
similar laws now or hereafter in effect relating to creditors’ rights generally, by an implied
covenant of good faith, reasonableness and fair dealing and by general principles of equity
(regardless of whether such enforceability is considered in a proceeding in equity or at law).

          5.2 Reservation of Warrant Shares. There have been reserved, and the Company shall at
all times during the term of the Warrant reserve and keep available, out of its authorized and
unissued shares of Common Stock, solely for the purpose of effecting the exercise of the Warrant,
the number of shares of Common Stock that shall from time to time be sufficient to provide for the
exercise of the rights of purchase represented by the outstanding Warrant. All shares of Common
Stock or other securities issued upon exercise of the Warrant will, upon issuance in accordance
with the terms hereof, be validly issued, fully paid and nonassessable, and free of all preemptive
rights.

     Section 6. Restrictions on Warrant Shares. The holder acknowledges and agrees that
the Warrant Shares issued upon exercise of the Warrant may not be sold, and that the holder will
not directly or indirectly offer or sell any of such Warrant Shares, other than in compliance with
the Securities Act and all other applicable state or foreign securities laws. To the extent
required by the Securities Act, each certificate representing the Warrant Shares shall be stamped
or otherwise imprinted with a legend in the following form (in addition to any legend required
under applicable state securities laws):

“THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT
WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. SUCH
SHARES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF
AN EFFECTIVE REGISTRATION STATEMENT THEREUNDER OR AN EXEMPTION FROM SUCH
REGISTRATION.”

-7-

 

     Section 7. Mutilated or Missing Warrant. If this Warrant shall be mutilated, lost,
stolen or destroyed and the Company shall receive evidence thereof and (except with respect to
mutilated Warrants returned to the Company) indemnity reasonably satisfactory to it, then the
Company shall issue and deliver in exchange and substitution for and upon cancellation of the
mutilated Warrant, or in lieu of and substitution for the Warrant lost, stolen or destroyed, a new
Warrant of like tenor and representing an equivalent right or interest. An applicant for such a
substitute Warrant shall comply with such other reasonable requirements and pay such reasonable
charges as the Company may prescribe, including, without limitation, the execution and delivery of
a lost Warrant affidavit and indemnification agreement in a form reasonably satisfactory to the
Company and its counsel.

     Section 8. No Rights as Stockholder. Except as provided in Section 2.1 and 1.2(d)
hereof, nothing contained in this Warrant shall be construed as conferring upon the holder the
right to vote or to receive dividends or to consent or to receive notice as stockholders in respect
of any meeting of stockholders for the election of directors of the Company or any other matter, or
any rights whatsoever as stockholders of the Company.

     Section 9. Notice to Holder. At any time prior to the Expiration Date, if any of the
following events shall occur:

	 	(i)	 	the Company shall declare any dividend or other distribution on the Common
Stock (other than a stock split by way of a stock dividend); or
	 
	 	(ii)	 	the Company shall take a record of the holders of Common Stock for the purpose
of entitling them to subscribe for or purchase shares of Common Stock;

then, to the extent practicable and subject to any confidentiality restrictions, the Company shall
give notice in writing of such event to the holder of the Warrant at least ten (10) Business Days
prior to the date fixed as a record date or the date of closing the transfer books for the
determination of the stockholders entitled to such dividend or other distribution or subscription
rights. No failure to give such notice or any defect therein or in the mailing thereof shall
affect the validity of the corporate action required to be specified in such notice.

     Section 10. Notices. All notices and other communications required or permitted to be
given with respect to the Warrant shall be in writing signed by the sender, and shall be considered
given: (w) on the date delivered, if personally delivered during normal business hours, or on the
next Business Day if delivered after normal business hours of the recipient; (x) on the date sent
by telecopier with automatic confirmation of the transmitting machine showing the proper number of
pages were transmitted without error, if sent during normal business hours of the recipient, or on
the next Business Day if sent after normal business hours; (y) on the Business Day after being sent
by Federal Express or another recognized overnight delivery service in time for and specifying next
day or next business day delivery; or (z) five (5) Business Days after mailing, if mailed by United
States postage-paid certified or registered mail, return receipt requested, in each instance
referred to in the preceding clauses (y) and (z) only if all delivery charges are pre-paid. Each
such notice or other communication shall be given to the

-8-

 

holder at the address in a Warrant register to be created and maintained by the Company and to
the Company at its principal executive offices.

     Section 11. No Waivers; Remedies; No Impairment. Prior to the Expiration Date, no
failure or delay by the holder in exercising any right, power or privilege with respect to the
Warrant shall operate as a waiver of the right, power or privilege. A single or partial exercise
of any right, power or privilege shall not preclude any other or further exercise of the right,
power or privilege or the exercise of any other right, power or privilege. The rights and remedies
provided in the Warrant shall be cumulative and not exclusive of any rights or remedies provided by
law. The Company will not, by amendment of its Certificate of Incorporation or through any other
means, directly or indirectly, avoid or seek to avoid the observance or performance of any of the
terms of this Warrant and will at all time in good faith assist in the carrying out of all such
terms and in the taking of all such actions as may be necessary or appropriate in order to protect
the rights of the holder of this Warrant against impairment.

     Section 12. Amendments. No amendment, modification, termination or waiver of any
provision of the Warrant, and no consent to any departure from any provision of the Warrant, shall
be effective unless it shall be in writing and signed and delivered by the Company and the holder,
and then it shall be effective only in the specific instance and for the specific purpose for which
it is given.

     Section 13. Governing Law. This Warrant shall be governed by and construed in
accordance with the laws of the State of New York that apply to contracts made and performed
entirely within such state.

     Section 14. Severability of Provisions: Successors. Any provision of this Warrant
that is prohibited or unenforceable in any jurisdiction shall, as to that jurisdiction, be
ineffective to the extent of the prohibition or unenforceability without invalidating the remaining
provisions of the Warrant or affecting the validity or enforceability of the provision in any other
jurisdiction. This Warrant shall be binding upon any entity succeeding the Company by merger,
consolidation or otherwise. This Warrant shall not be assignable by the Company without the prior
written consent of the holder. All of the covenants and agreements of the Company shall inure to
the benefit of successors and assigns of the holder.

     Section 15. Headings and References. Headings in the Warrant are included for the
convenience of reference only and do not constitute a part of the Warrant for any other purpose.
References to sections in the Warrant are references to the sections of the Warrant, unless the
context shall require otherwise.

     Section 16. Definitions. For purposes of this Warrant, the following terms have the
following meanings:

               (a) “Affiliate” of any Person means any Person, directly or indirectly, controlling,
controlled by or under common control with such Person.

               (b) “Business Day” means any day excluding Saturday, Sunday and any day which is a legal
holiday under the laws of the State of New York or is a day on which

-9-

 

banking institutions located in such state are authorized or required by law or other
governmental action to close.

               (c) “Exchange Act” means the Securities Exchange Act of 1934, as amended.

               (d) “FSA” means the Financial Services Authority.

               (e) “FSA Approval” means the approval by the FSA of the Purchasers and their relevant
Affiliates acquiring “control” of MarketAxess Europe Limited pursuant to the transactions
contemplated by the Purchase Agreement and the Related Agreements, where “control” has the meaning given to
it in the FSA Rules.

               (f) “FSA Rules” means the rules, requirements, guidance and directions issued by the FSA.

               (g) “HSR Clearance” means the expiration or termination or any waiting period under the
Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended applicable to the exercise of the
Warrant and the issuance of the Warrant Shares.

               (h) “Investor Rights Agreement” means the Investor Rights Agreement dated as of the date
hereof, among the Company and the other parties set forth therein, as it may be amended, restated,
modified or supplemented from time to time.

               (i) “person” means a “person” within the meaning of Section 3(a)(9) of the Exchange Act.

               (j) “Related Agreements” means this Warrant, the Purchase Agreement and the Investor Rights Agreement.

               (k) “Trading Day” means, as applied to any class of stock, any day on which NASDAQ or, if such
stock is not listed on NASDAQ, the exchange or market which is the primary market for such stock,
is open for the trading of securities generally and with respect to which information regarding the
sale of securities included therein, or with respect to which sales information is reported, is
generally available

[The next page is the signature page]

-10-

 

     The Company has executed and delivered this Warrant as of the date set forth above.

	 	 	 	 	 	 	 	 	 
	 	 	 	 	MARKETAXESS HOLDINGS INC.	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	By:	 	 	 	 
	 

	 	 	 	 	 	 

	 	 
	 

	 	 	 	 	 	Name:	 	 
	 

	 	 	 	 	 	Title:	 	 
	Accepted:
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	[TCV VI, L.P / TCV Member Fund L.P.]
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	By: Technology Crossover Management VI,

L.L.C., its General Partner
	 	 	 	 	 	 	 	 
	 
	 
	 	 	 	 	 	 	 	 
	 

By: Carla S. Newell

	 	 	 	 	 	 	 	 
	Title: Attorney-in-Fact
	 	 	 	 	 	 	 	 

S-1

 

NOTICE OF EXERCISE

(To Be Completed Only Upon Exercise)

	 	 	 
	TO:

	 	MarketAxess Holdings Inc.
	 

	 	140 Broadway, 42nd Floor
	 

	 	New York, New York 10005
	 

	 	Attention: Secretary

     1. The undersigned hereby irrevocably elects to exercise the Warrant with respect to
___Warrant Shares pursuant to the terms of the Warrant.

     2. If Cash Exercise, check this box o: The undersigned tenders herewith full payment of
the aggregate cash exercise price equal to $___U.S. Dollars for such shares in
accordance with the terms of the Warrant.

     3. If Net-Issue Exercise, check this box o: The undersigned exercises the Warrant on a
net-issue basis pursuant to the terms set forth in the Warrant. Net-Issue Information:

	 	 	 
	     (a) Number of Warrant Shares to be Issued to Holder:
	 	 
	 

	 	 

	 	 	 
	     (b) Number of Warrant Shares Subject to Warrant Surrendered:
	 	 
	 

	 	 

	 	 	 
	     (c) Number of Warrant Shares Remaining Subject to Warrant, if any:
	 	 
	 

	 	 

     4. In accordance with Section 1.2(d) of the Warrant, by checking this box  ̈, the holder
hereby notifies the Company that HSR Clearance or FSA Approval is required in connection with the
exercise of the Warrant, and that the issuance of Warrant Shares shall be delayed until the Company
receives written notice from the holder that such holder has obtained HSR Clearance or FSA
Approval, as applicable, and provides the Company with evidence thereof that is reasonably
satisfactory to the Company.

     5. Please issue a certificate or certificates representing said Warrant Shares in such name or
names as specified below:

      

(Name and Address)

      

      

     6. The undersigned acknowledges that if the undersigned is deemed to be an affiliate of the
issuer of the Warrant Shares under the federal securities laws, the undersigned may be subject to
certain restrictions on, or subject to certain procedural requirements in connection with, any
transfer of the Warrant Shares issued upon exercise of the Warrant.

     7. The undersigned hereby represents and warrants to the Company as follows: (i) the
undersigned is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D
promulgated under the Securities Act; (ii) the undersigned has been advised by the Company that
such Warrant Shares have not been registered under the Securities Act; (iii) the undersigned
acknowledges that he, she or it has been informed by the Company of, or is otherwise familiar with,
the nature of the limitations imposed by the

 

 

Securities Act and the rules and regulations thereunder on the transfer of securities; (iv)
the undersigned is acquiring such Warrant Shares for his, her or its own account and not with a
view to, or for sale in connection with, any distribution thereof in violation of federal or state
securities laws; (v) by reason of his, her or its business or financial experience, the undersigned
has the capacity to protect his, her or its own interest in connection with the issuance of such
Warrant Shares; (vi) the undersigned recognizes that investing in the Company involves substantial
risks, and has taken full cognizance of and understands all of the risk factors related to the
acquisition of such Warrant Shares; (vii) the undersigned has carefully considered and has, to the
extent he, she or it believes such discussion necessary, discussed with such transferee’s
professional legal, tax and financial advisers the suitability of an investment in the Company, and
such transferee has determined that the acquisition of such Warrant Shares is a suitable investment
for the undersigned; (viii) the undersigned has not relied on the Company for any tax or legal
advice in connection with the exercise of this Warrant and (ix) in evaluating the suitability of an
investment in the Company, that except for information made publicly available by the Company
pursuant to filings with the Securities and Exchange Commission, by press release or otherwise, the
undersigned has not relied upon any representations or other information from the Company or any of
its agents.

	 	 	 	 	 	 	 	 	 
	Determination Date:

	 	 	 	 	 	By:	 	 
	 

	 	 
	 	 	 	 	 	 

(Signature must conform in all respects to name of the holder as set forth on the face of the
Warrant)

 

 

NOTICE OF TRANSFER

(To Be Completed Only Upon Transfer)

	 	 	 
	TO:

	 	MarketAxess Holdings Inc.
	 

	 	140 Broadway, 42nd Floor
	 

	 	New York, New York 10005
	 

	 	Attention: Secretary

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto
                                         the right represented by this Warrant, to purchase
                     Warrant Shares.

Please issue a Warrant representing the right to purchase such Warrant Shares in such name or
names as specified below:

      

(Name and Address)

      

      

     The undersigned requests the Company, by written order to exchange or register the transfer of
a Warrant or Warrants, and, to the extent the transfer contemplated by this notice is not for the
entire number of Warrant Shares represented by this Warrant, to issue a replacement Warrant in the
name of the undersigned representing the balance of such Warrant Shares.

	 	 	 	 	 	 	 	 	 
	Dated:

	 	 	 	 	 	By:	 	 
	 

	 	 
	 	 	 	 	 	 

(Signature must conform in all respects to name of the holder as set forth on the face of this
Warrant)EX-10.1

Exhibit 10.1

SECURITIES PURCHASE AGREEMENT

Dated as of June 2, 2008

AMONG

MARKETAXESS HOLDINGS INC.

TCV VI, L.P.

AND

TCV MEMBER FUND, L.P.

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	ARTICLE I PURCHASE AND SALE OF SHARES
	 	 	1	 
	 
	 	 	 	 
	1.1 Purchase and Sale
	 	 	 1	 
	1.2 Closing
	 	 	 1	 
	 
	 	 	 	 
	ARTICLE II REPRESENTATIONS AND WARRANTIES OF THE COMPANY
	 	 	2	 
	 
	 	 	 	 
	2.1 Organization and Corporate Power
	 	 	 2	 
	2.2 Authorization, Etc.
	 	 	 2	 
	2.3 Government Approvals
	 	 	 3	 
	2.4 Authorized and Outstanding Stock
	 	 	 3	 
	2.5 Subsidiaries
	 	 	 4	 
	2.6 Securities Law Compliance
	 	 	 5	 
	2.7 SEC Documents; Financial Information
	 	 	 5	 
	2.8 Internal Controls
	 	 	 6	 
	2.9 Disclosure Controls
	 	 	 6	 
	2.10 Absence of Certain Events; No Material Adverse Change
	 	 	 6	 
	2.11 Litigation
	 	 	 8	 
	2.12 Compliance with Laws; Permits
	 	 	 8	 
	2.13 Taxes
	 	 	 9	 
	2.14 Intellectual Property
	 	 	 9	 
	2.15 Contracts and Commitments
	 	 	10	 
	2.16 Employee Matters
	 	 	10	 
	2.17 No Brokers or Finders
	 	 	10	 
	2.18 Transactions with Affiliates
	 	 	10	 
	2.19 Insurance
	 	 	11	 
	2.20 Investment Company Act
	 	 	11	 
	2.22 Nasdaq
	 	 	11	 
	2.23 Delaware Section 203
	 	 	11	 
	 
	 	 	 	 
	ARTICLE III REPRESENTATIONS AND WARRANTIES OF EACH PURCHASER
	 	 	11	 
	 
	 	 	 	 
	3.1 Organization and Power
	 	 	11	 
	3.2 Authorization, Etc.
	 	 	11	 
	3.3 Government Approvals
	 	 	12	 
	3.4 Investment Representations
	 	 	12	 
	3.5 No Brokers or Finders
	 	 	13	 
	 
	 	 	 	 
	ARTICLE IV COVENANTS OF THE PARTIES
	 	 	13	 
	 
	 	 	 	 
	4.1 Legends
	 	 	13	 
	4.2 Restrictions on Actions
	 	 	13	 
	4.3 Hedging Transactions
	 	 	15	 
	4.4 TCV Director
	 	 	16	 
	4.5 Rights Agreement
	 	 	17	 
	4.6 Specific Performance
	 	 	17	 

i  

 

	 	 	 	 	 
	ARTICLE V CONDITIONS TO THE PURCHASERS’ OBLIGATION
	 	 	18	 
	 
	 	 	 	 
	5.1 Initial Closing
	 	 	18	 
	5.2 Subsequent Closing
	 	 	19	 
	 
	 	 	 	 
	ARTICLE VI CONDITIONS TO THE COMPANY’S OBLIGATION
	 	 	20	 
	 
	 	 	 	 
	6.1 Initial Closing
	 	 	20	 
	6.2 Subsequent Closing
	 	 	20	 
	 
	 	 	 	 
	ARTICLE VII MISCELLANEOUS
	 	 	21	 
	 
	 	 	 	 
	7.1 Survival of Representations
	 	 	21	 
	7.2 Shares Owned by Affiliates
	 	 	21	 
	7.3 Counterparts
	 	 	22	 
	7.4 Governing Law
	 	 	22	 
	7.5 Entire Agreement; No Third Party Beneficiary
	 	 	22	 
	7.6 Expenses
	 	 	23	 
	7.7 Notices
	 	 	23	 
	7.8 Successors and Assigns
	 	 	24	 
	7.9 Headings
	 	 	24	 
	7.10 Amendments and Waivers
	 	 	24	 
	7.11 Interpretation; Absence of Presumption
	 	 	24	 
	7.12 Severability
	 	 	25	 

ii  

 

SCHEDULES

	 	 	 
	Schedule 1.1

	 	Purchased Shares and Warrant Shares

EXHIBITS

	 	 	 
	Exhibit A

	 	Definitions
	Exhibit B-1

	 	Form of Certificate of Designation of Series B Preferred Stock
	Exhibit B-2

	 	Form of Warrant
	Exhibit C

	 	Investor Rights Agreement
	Exhibit D

	 	Form of Opinion of Company Counsel

iii  

 

SECURITIES PURCHASE AGREEMENT

     This Securities Purchase Agreement dated as of June 2, 2008 (this “Agreement”) is among
MarketAxess Holdings Inc., a Delaware corporation (the “Company”), TCV VI, L.P., a Delaware limited
partnership (“TCV VI”), and TCV Member Fund, L.P., a Delaware limited partnership (“TCV Member
Fund” and, together with TCV VI, the “Purchasers”). Capitalized terms used but not defined herein
have the meanings assigned to them in Exhibit A.

     The Purchasers desire to purchase from the Company, and the Company desires to issue and sell
to the Purchasers, (i) an aggregate of 35,000 shares (the “Purchased Shares”) of the Company’s
Series B Preferred Stock, par value $0.001 per share (“Series B Preferred Stock”), and (ii) one or
more warrants (the “Warrants” ) to purchase an aggregate of 700,000 shares (the “Warrant Shares” )
of Common Stock, all on the terms and subject to the conditions hereinafter set forth.

     In consideration of the premises and the mutual representations, warranties, covenants and
agreements contained herein, and for other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties agree as follows:

ARTICLE I

PURCHASE AND SALE OF SECURITIES

     Section 1.1 Purchase and Sale. Subject to the terms and conditions hereinafter set
forth, at the applicable Closing each Purchaser shall purchase, and the Company shall issue and
sell, that number of Purchased Shares and a Warrant for that number of Warrant Shares set forth
below such Purchaser’s name for the applicable Closing on Schedule 1.1. The aggregate
purchase to be paid by each Purchaser at the applicable Closing is set forth on Schedule
1.1. The Series B Preferred Stock shall have the rights, terms and privileges set forth in the
Certificate of Designation of Series B Preferred Stock (the “Certificate of Designation”) attached
as Exhibit B-1 and the Warrants shall be in the form attached as Exhibit B-2.

     Section 1.2 Closings.

     (a) On the terms and subject to the satisfaction or waiver of the conditions set forth in
this Agreement, the initial closing of the sale and purchase of the Purchased Shares and the
Warrants (the “Initial Closing”) shall take place at the offices of Latham & Watkins LLP, 885 Third
Avenue, New York, New York, at 10:00 A.M., on the first business day after the day on which all of
the conditions set forth in Sections 5.1 and 6.1 have been satisfied or waived (other than
conditions which by their terms are to be satisfied at the Initial Closing), or such other time and
place as the Company and the Purchasers may agree. The date on which the Initial Closing is to
occur is herein referred to as the “Initial Closing Date.” At the Initial Closing, the Company
will deliver the Purchased Shares and the Warrants being acquired by each Purchaser at the Initial
Closing in the form of one or more certificates issued in such Purchaser’s name upon receipt by the
Company of payment of the full purchase price to be paid at the Initial Closing therefor by or on
behalf of such Purchaser to the Company by certified check or by wire transfer of immediately
available funds to an account designated in writing by the Company.

 

 

     (b) On the terms and subject to the satisfaction or waiver of the conditions set forth in
this Agreement, the subsequent closing of the sale and purchase of the Purchased Shares and the
Warrants (the “Subsequent Closing” and collectively with the Initial Closing, the “Closings”) shall
take place at the offices of Latham & Watkins LLP, 885 Third Avenue, New York, New York, at 10:00
A.M., on the first business day after the day on which all of the conditions set forth in Sections
5.2 and 6.2 have been satisfied or waived (other than conditions which by their terms are to be
satisfied at the Subsequent Closing), or such other time and place as the Company and the
Purchasers may agree. The date on which the Subsequent Closing is to occur is herein referred to
as the “Subsequent Closing Date.” At the Subsequent Closing, the Company will deliver the
Purchased Shares and the Warrants being acquired by each Purchaser at the Subsequent Closing in the
form of one or more certificates issued in such Purchaser’s name upon receipt by the Company of
payment of the full purchase price to be paid at the Subsequent Closing therefor by or on behalf of
such Purchaser to the Company by certified check or by wire transfer of immediately available funds
to an account designated in writing by the Company.

ARTICLE II

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

     The Company represents and warrants to the Purchasers that, except as set forth in the SEC
Documents filed by the Company with the SEC on or after January 1, 2008 (other than disclosures in
the “Risk Factors” sections of any such filings and any other disclosures included in such filings
to the extent such disclosures are predictive or forward-looking in nature):

     Section 2.1 Organization and Power. The Company and each of its Subsidiaries is a
corporation validly existing and in good standing under the laws of the jurisdiction of its
incorporation and has all requisite corporate power and authority to own its properties and to
carry on its business as presently conducted and as proposed to be conducted. The Company and each
of its Subsidiaries is duly licensed or qualified to do business as a foreign corporation or
limited liability company in each jurisdiction wherein the character of its property or the nature
of the activities presently conducted by it, makes such qualification necessary, except where the
failure to so qualify has not, individually or in the aggregate, had, and would not reasonably be
expected to have, a Material Adverse Effect.

     Section 2.2 Authorization, Etc. The Company has all necessary corporate power and
authority and has taken all necessary corporate action required for the due authorization,
execution, delivery and performance by the Company of this Agreement, the Warrants and the Investor
Rights Agreement (collectively, the “Related Agreements”), and the consummation by the Company of
the transactions contemplated hereby and thereby, the filing of the Certificate of Designation with
the Secretary of State of the State of Delaware and for the due authorization, issuance, sale and
delivery of the Purchased Shares and the Warrants and the reservation, issuance and delivery of the
Conversion Shares and the Warrant Shares. The authorization, execution, delivery and performance
by the Company of this Agreement and the Related Agreements, and the consummation by the Company of
the transactions contemplated hereby and thereby, including the filing of the Certificate of
Designation and the issuance of the Purchased Shares, the Warrants, the Conversion Shares and the
Warrant Shares do not and will

-2-

 

not: (a) violate or result in the breach of any provision of the certificate of incorporation
and bylaws of the Company; or (b) with such exceptions that would not reasonably be expected to
have a Material Adverse Effect, whether after the giving of notice or the lapse of time or both:
(i) violate any provision of, constitute a breach of, or default under, or result in or permit the
cancellation, termination or acceleration of any judgment, order, writ, or decree applicable to the
Company or any of its Subsidiaries or any license agreement, securities or registration rights
agreement, mortgage, credit or hedging agreement, indebtedness or other agreement or contract to
which the Company or any of its Subsidiaries is a party; (ii) violate any provision of, constitute
a breach of, or default under, any applicable state, federal or local law, rule or regulation; or
(iii) result in the creation of any Lien upon any assets of the Company or any of its Subsidiaries
or the suspension, revocation, impairment, forfeiture or nonrenewal of any franchise, permit,
license or other right granted by a governmental authority to the Company or any of its
Subsidiaries, other than Liens under federal or state securities laws. The issuance of the
Purchased Shares does not require any further corporate action and is not subject to any preemptive
right under the Company’s certificate of incorporation or any contract to which the Company is a
party. This Agreement and each of the Related Agreements has been duly executed and delivered by
the Company. Assuming due execution and delivery thereof by each of the other parties thereto,
this Agreement and the Related Agreements will each be a valid and binding obligation of the
Company enforceable against the Company in accordance with its terms, except as such enforceability
may be limited by applicable laws relating to bankruptcy, insolvency, reorganization, moratorium or
other similar legal requirement relating to or affecting creditors’ rights generally and except as
such enforceability is subject to general principles of equity (regardless of whether
enforceability is considered in a proceeding in equity or at law).

     Section 2.3 Government Approvals. No consent, approval, license or authorization of,
or designation, declaration or filing with, any court or governmental authority is or will be
required on the part of the Company in connection with the execution, delivery and performance by
the Company of this Agreement and the Related Agreements, or in connection with the issuance of the
Purchased Shares, the Warrants, the Conversion Shares or the Warrant Shares, except for (a) the
filing of the Certificate of Designation with the Secretary of State of the State of Delaware; (b)
those which have already been made or granted; (c) the filing of a current report on Form 8-K with
the SEC; (d) filings with applicable state securities commissions; (e) the listing of the
Conversion Shares and the Warrant Shares with the Nasdaq Stock Market; (f) in compliance with the
provisions of the HSR Act in connection with any exercise of the Warrants; (g) FSA Approval; and
(h) filing an amended Form BD with the SEC.

     Section 2.4 Authorized and Outstanding Stock.

          (a) The authorized capital stock of the Company (immediately prior to the Closing) consists of
110,000,000 shares of Common Stock, 10,000,000 shares of nonvoting common stock, par value $0.003
per share (“Nonvoting Common Stock”) and 5,000,000 shares of preferred stock, par value $0.001 per
share (“Preferred Stock”), and upon the filing of the Certificate of Designation with the Secretary
of State of the State of Delaware 35,000 shares of Preferred Stock have been designated as the
Series B Preferred Stock.

          (b) As of May 28, 2008, the issued and outstanding capital stock of the Company consists of
30,988,380 shares of Common Stock (including unvested restricted stock

-3-

 

units (or RSUs) for an aggregate of 648,473 shares that have been granted under the Stock
Plans) and 2,585,654 shares of Nonvoting Common Stock. There are no outstanding shares of
Preferred Stock. In addition, options to purchase an aggregate of 5,726,396 shares of Common Stock
have been granted and are unexercised under the Stock Plans and such options have a weighted
average exercise price of $9.24 per share. All of the issued and outstanding shares of capital
stock of the Company are, and when issued in accordance with the terms hereof, the Purchased Shares
will be, duly authorized and validly issued and fully paid and non-assessable. The shares of
Common Stock issuable upon conversion of the Purchased Shares (the “Conversion Shares”) and upon
exercise of the Warrants have been reserved for issuance and, when issued upon conversion thereof
in accordance with the terms of the Certificate of Designation or upon exercise of the Warrants in
accordance with their respective terms, as the case may be, will be validly issued and fully paid
and non-assessable and will not be subject to any preemptive right or any restrictions on transfer
under applicable law or any contract to which the Company is a party, other than those under
applicable state and federal securities and antitakeover laws, this Agreement and the Investor
Rights Agreement. When issued in accordance with the terms hereof, the Purchased Shares will be
free and clear of all Liens imposed by or through the Company, except for restrictions imposed by
Federal or state securities or “blue sky” laws and except for those imposed pursuant to this
Agreement or the Investor Rights Agreement. The designations, powers, preferences, rights,
qualifications, limitations and restrictions in respect of each class or series of capital stock of
the Company are as set forth in the Company’s amended and restated certificate of incorporation,
including the Certificate of Designation.

          (c) Except as provided in this Agreement: (i) no subscription, warrant, option, convertible
security or other right issued by the Company to purchase or acquire any shares of capital stock of
the Company is authorized or outstanding; (ii) there is not any commitment of the Company to issue
any subscription, warrant, option, convertible security or other such right or to issue or
distribute to holders of any shares of its capital stock any evidences of indebtedness or assets of
the Company; (iii) the Company has no obligation to purchase, redeem or otherwise acquire any
shares of its capital stock or any interest therein or to pay any dividend or make any other
distribution in respect thereof; and (iv) there are no agreements between the Company and any
holder of its capital stock relating to the acquisition, disposition or voting of the capital stock
of the Company. No person or entity is entitled to any preemptive right granted by the Company
with respect to the issuance of any capital stock of the Company. Except as provided in the
Investor Rights Agreement, no person or entity has been granted rights by the Company with respect
to the registration of any capital stock of the Company under the Securities Act of 1933, as
amended (the “Securities Act”).

     Section 2.5 Subsidiaries. The Company’s Subsidiaries consist of (i) all the entities
listed on Exhibit 21.1 to the Company’s Form 10-K for the year ended December 31, 2007 other than MarketAxess Leasing Limited which has been dissolved, and (ii)
Greenline Financial Technologies, Inc. The Company, directly or indirectly, owns of record and
beneficially, free and clear of all Liens of any nature, all of the issued and outstanding capital
stock of each of its Subsidiaries. All of the issued and outstanding capital stock or equity
interests of the Company’s Subsidiaries has been duly authorized and validly issued, and in the
case of corporations, is fully paid and non-assessable. There are no outstanding rights, options,
warrants, preemptive rights, conversion rights, rights of first refusal or similar rights for the
purchase or acquisition from any of the Company’s Subsidiaries of any securities of such

-4-

 

Subsidiaries nor are there any commitments to issue or execute any such rights, options,
warrants, preemptive rights, conversion rights or rights of first refusal. The Company is not a
participant in any material joint venture, partnership or similar arrangement.

     Section 2.6 Securities Law Compliance. Assuming the accuracy of the representations
and warranties of the Purchasers set forth in Section 3.4 (Investment Representations), the offer
and sale of the Purchased Shares pursuant to this Agreement will be exempt from the registration
requirements of the Securities Act. The Company has not, in connection with the transactions
contemplated by this Agreement, engaged in: (a) any form of general solicitation or general
advertising (as those terms are used within the meaning of Rule 502(c) promulgated under the
Securities Act); (b) any action involving a “public offering” within the meaning of Section 4(2) of
the Securities Act; or (c) any action that would require the registration under the Securities Act
of the offering and sale of the Purchased Shares or the Warrants pursuant to this Agreement. As
used herein, the terms “offer” and “sale” have the meanings specified in Section 2(3) of the
Securities Act.

     Section 2.7 SEC Documents; Financial Information; Undisclosed Liabilities. Since
January 1, 2007, the Company and each Subsidiary that is registered with the SEC as a broker-dealer
has timely filed (a) all annual and quarterly reports and proxy statements (including all
amendments, exhibits and schedules thereto) and (b) all other reports and other documents
(including all amendments, exhibits and schedules thereto), in each case required to be filed by
the Company with the SEC pursuant to the Exchange Act and the Securities Act except, in the case of
clause (b), where the failure to file has not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. Since January 1, 2007, each
Subsidiary of the Company that is registered with the SEC or with the FSA as a broker, dealer,
arranger or other market intermediary or participant has timely filed all material reports,
schedules, and other documents (including all required amendments, exhibits and schedules thereto)
required to be filed by such entity with FINRA or the FSA pursuant to the Exchange Act and/or the
rules administered by FINRA or the FSA (together with the SEC Documents, the “Documents”). As of
their respective filing dates, the Documents complied in all material respects with the
requirements of the Securities Act, the Exchange Act and the rules and regulations of the SEC (or
FINRA or the FSA, as applicable) thereunder applicable to such Documents, and as of their
respective dates none of the Documents contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading. The financial
statements of the Company and its Subsidiaries included in the SEC Documents (the “Financial
Statements”) comply as of their respective dates in all material respects with applicable
accounting requirements and the rules and regulations of the SEC with respect thereto (except as
may be indicated in the notes thereto or, in the case of the unaudited statements, as permitted by
Form 10-Q promulgated by the SEC), and present fairly in all material respects as of their
respective dates the consolidated financial position of the Company and its Subsidiaries as at the
dates thereof and the consolidated results of their operations and their consolidated cash flows
for each of the respective periods, all in conformity with GAAP. The Company satisfies the
“registrant requirements” for use of Form S-3 set forth in General Instruction I.A to Form S-3
promulgated by the SEC. Except (a) as disclosed in the Company’s March 31, 2008 balance sheet or
in the SEC Documents, (b) for liabilities incurred since March 31, 2008 in the ordinary course of
business, and (c) for liabilities

-5-

 

incurred in connection with contracts or agreements entered into in the ordinary course of business
or in connection with this Agreement or the transactions contemplated hereby, the Company and its
Subsidiaries do not have any liabilities, either accrued, contingent or otherwise, and whether due
or to become due, which have had or would reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect.

     Section 2.8 Internal Controls. The Company and each of its Subsidiaries maintains a
system of internal control over financial reporting that the Company believes are sufficient to
provide reasonable assurance that: (a) transactions are executed in accordance with management’s
general or specific authorization; (b) transactions are recorded as necessary to permit preparation
of financial statements in conformity with GAAP and to maintain accountability for assets; and (c)
access to assets is permitted only in accordance with management’s general or specific
authorization. The Company believes that its auditors and the Audit Committee of the Board of
Directors have been advised of: (x) any significant deficiencies in the design or operation of the
Company’s internal control over financial reporting that are reasonably likely to adversely affect
the Company’s ability to record, process, summarize and report financial data; and (y) any fraud,
whether or not material, that involves management or other employees who have a significant role in
the Company’s internal control over financial reporting. Any material weaknesses in the Company’s
internal control over financial reporting as of the date the last evaluation was conducted have
been identified for the Company’s auditors. Each Subsidiary of the Company that is registered with
the SEC as a broker-dealer maintains a system of supervisory controls and supervisory procedures,
including procedures to test and verify such supervisory procedures, sufficient to meet the
requirements of NASD Rules 3010, 3011, 3012, and 3013.

     Section 2.9 Disclosure Controls. The Company has established and maintains disclosure
controls and procedures (as such term is defined in Rule 13a-15 and 15d-15 under the Exchange Act).
Such disclosure controls and procedures are designed to provide reasonable assurance that material
information relating to the Company, including its Subsidiaries, that is required to be disclosed
by the Company in the reports that it furnishes or files under the Exchange Act is reported within
the time periods specified in the rules and forms of the SEC and that such material information is
communicated to the Company’s management to allow timely decisions regarding required disclosure.

     Section 2.10 Absence of Certain Events; No Material Adverse Change. Since December
31, 2007, the Company and its Subsidiaries each has conducted its business operations in the
ordinary course and there has not occurred any event, development, circumstance or condition that,
individually or in the aggregate, has had or is reasonably likely to have a Material Adverse
Effect. Without limiting the generality of the foregoing, since December 31, 2007 there has not
occurred:

          (a) any purchase, sale, transfer, assignment, conveyance or pledge of the assets or properties
of the Company or any of its Subsidiaries, except in the ordinary course of business;

-6-

 

          (b) any incurrence of indebtedness for borrowed money, notes, mortgages or purchase money
indebtedness of the Company or its Subsidiaries in excess of $1,000,000 in the aggregate;

          (c) any waiver or modification by the Company or any of its Subsidiaries of any right or
rights of substantial value or of a material debt owed to it other than in the ordinary course of
business;

          (d) any material change in the accounting principles, methods, practices or procedures
followed by the Company in connection with the business of the Company and its Subsidiaries or any
material change in the depreciation or amortization policies or rates theretofore adopted by the
Company in connection with the business of the Company and its Subsidiaries, any change in the
Company’s independent public accounting firm, disagreement with its independent public accounting
firm over the Company’s and its Subsidiaries’ application of accounting principles or with the
preparation of any of their financial statements that was required to be disclosed in the SEC
Documents, notification to the Company’s audit committee of any irregularity with respect to the
Company’s or its Subsidiaries’ financial statements, books and records or method of accounting;

          (e) except as contemplated by this Agreement, any declaration, setting aside or payment of any
dividends (or, in the case of a limited liability company, other distributions) in respect of the
outstanding shares of capital stock (or, in the case of a limited liability company, other equity
interests) of the Company or any of its Subsidiaries (other than dividends declared or paid by
wholly-owned Subsidiaries to the Company or another wholly-owned Subsidiary of the Company) or any
other change in the authorized capitalization of the Company or any of its Subsidiaries or any
direct or indirect redemption, purchase or other acquisition of any such stock by the Company;

          (f) any written notice from the SEC in connection with any investigation or action by the SEC
that seeks to, or could reasonably be expected to result in, the restatement by the Company of any
of its current or previously disclosed financial statements, and to the actual knowledge of any of
the executive officers of the Company, no such investigation or action has been threatened in
writing by the SEC;

          (g) any material change in any compensation agreement or arrangement with any executive
officer or director of the Company, other than in the ordinary course of business;

          (h) any resignation or termination of employment of any of the Company’s executive officers
and the Company is not aware of any impending resignation or termination of any such officer;

          (i) any loans or guarantees made by the Company or any of its Subsidiaries to or for the
benefit of their employees, officers or directors or any members of their immediate families, other
than (i) travel advances and other advances made in the ordinary course of business and (ii) loans
to employees, officers or directors in connection with the exercise of stock options granted
pursuant to the Stock Plans;

-7-

 

          (j) the withdrawal or termination, or any written notice threatening withdrawal or
termination, of any broker-dealer as a participant in the Company’s or its Subsidiaries trading
platforms;

          (k) any arrangement, contract or commitment to do any of the foregoing;

          (l) any written notice from any governmental authority (to include any non-U.S. governmental
authority or self-regulatory organization) that seeks to commence, or would reasonably be expected
to result in, the commencement of an enforcement action against the Company or against any
Subsidiary that is registered with the SEC as a broker-dealer.

     Section 2.11 Litigation. There is no litigation or governmental proceeding pending
or, to the knowledge of the Company, threatened in writing, against the Company or any of its
Subsidiaries or affecting any of the business, operations, properties or assets of the Company or
any of its Subsidiaries which would reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect. Neither the Company nor any Subsidiary is in default with
respect to any order, writ, injunction, decree, ruling or decision of any court, commission, board
or other government agency that is expressly applicable to the Company or any Subsidiary or any of
their assets or property which would reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect.

     Section 2.12 Compliance with Laws; Permits.

     (a) The Company is not in violation of or default under any provision of its restated
certificate of incorporation or bylaws, each as currently in effect. The Company and its
Subsidiaries are in compliance in all material respect with all material statutes and regulations
(whether issued under domestic, foreign or international law), including the FSA Rules. The
Company and its Subsidiaries have each conducted and continue to conduct business operations in
accordance with all law and regulation applicable to the Company or any Subsidiary, and neither the
Company nor any Subsidiary is in violation of any such law or regulation, except in each case for
violations which would not reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect. The Company is not subject to material regulation in any jurisdiction other than the United States, the United Kingdom, Canada and the member states of the European Union and any political subdivision of any of the foregoing.

     (b) Without limiting the generality of the preceding paragraph, with respect to its business
operations and with such exceptions as would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect:

          (i) the Company, and each of its Subsidiaries, by virtue of broker-dealer activities, is not
required to be registered in or obtain a franchise, permit, license or similar authorization (each,
a “Permit”) from any jurisdiction, other than those Permits currently held, and, as a
broker-dealer, has not exceeded in any material respect those business activities in which it is
authorized by governmental authorities to engage as enumerated in any agreements with any
governmental authority or any other limitations imposed in connection with their registration
forms;

-8-

 

          (ii) all such Permits held by the Company or any Subsidiary are in full force and effect and,
to the knowledge of the Company, no suspension or cancellation of any of them has been threatened
in writing;

          (iii) neither the Company nor any of its Subsidiaries has failed to pay any material fees and
assessments due and payable in connection with any filing; and

          (iv) none of the Company or any of its Subsidiaries is subject to a “statutory
disqualification” as defined in Section 3(a)(39) of the Exchange Act.

     (c) Except for normal examinations conducted by the SEC, FSA or a self-regulatory organization
in the regular course of the Company’s and its Subsidiaries’ business, (i) neither the SEC, FSA nor
any self-regulatory organization has initiated any proceeding or investigation into the business or
operations of the Company or any of its Subsidiaries and (ii) there is no unresolved violation or
exception by the SEC, FSA or any self-regulatory organization with respect to any report or
statement relating to any examinations of the Company or any of its Subsidiaries.

     Section 2.13 Taxes. The Company and each of its Subsidiaries has filed all Tax
returns required to be filed within the applicable periods for such filings (with due regard to any
extension) and has paid all Taxes required to be paid, except for any such failures to file or pay
that would not individually or in the aggregate reasonably be expected to have a Material Adverse
Effect. No material deficiencies for any Tax are currently assessed against the Company or any of
its Subsidiaries, and no material Tax returns of the Company or any of its Subsidiaries have been audited
during the last three years, and, there is no such material audit pending or, to the knowledge of the
Company, contemplated. There is no outstanding claim by an authority in a jurisdiction
where the Company does not file tax returns that it is or may be subject to the imposition of any
material tax by that jurisdiction.

     Section 2.14 Intellectual Property. All material Intellectual Property Rights
purported to be owned by the Company or any of its Subsidiaries that were developed, worked on or
otherwise held by any employee, officer, consultant or otherwise are owned free and clear by the
Company or one of its Subsidiaries (as the case may be) by operation of law or have been validly
assigned to the Company one of its Subsidiaries (as the case may be) in all material respects. The
Intellectual Property Rights are sufficient in all material respects to carry on the business of
the Company and each of its Subsidiaries as presently conducted. To the actual knowledge of the
Company, the Intellectual Property Rights owned by the Company or any of its Subsidiaries do not
infringe the intellectual property rights of any third party. Neither the Company nor any of its
Subsidiaries has received since the later of January 1, 2007 and (with respect to each Subsidiary
of the Company that was acquired from one or more third parties) the date such Subsidiary was
acquired from such third party(ies) any written notice or other written claim from any third party:
(i) asserting that any of the Intellectual Property Rights purported to be owned by the Company or
any of its Subsidiaries infringe any intellectual property rights of such third

-9-

 

party; (ii) challenging the validity, effectiveness or ownership by the Company or its
Subsidiaries of any of the Intellectual Property Rights; or (iii) asserting that the Company or its
Subsidiaries is in material default with respect to any license granting Intellectual Property
Rights to the Company or its Subsidiaries.

     Section 2.15 Contracts and Commitments. All of the material contracts of the Company
or any of its Subsidiaries are in full force and effect and upon consummation of the transactions
contemplated by this Agreement and the Related Agreements, shall continue in full force and effect
in all material respects. Neither the Company nor any of its Subsidiaries nor, to the actual
knowledge of the Company, any other party is in material breach of or in material default under any
such contract.

     Section 2.16 Employee Matters. The Company has described in, or filed as an exhibit
to, the SEC Documents filed prior to the date of this Agreement all of the following types of
documents, agreements, plans or arrangements that are required by federal securities laws to be
described in, or filed as an exhibit to, the SEC Documents: employment agreements, consulting
agreements, deferred compensation, pension or retirement agreements or arrangements (including all
“employee pension benefit plans” as defined in Section 3(2) of ERISA, bonus, incentive or
profit-sharing plans or arrangements, or labor or collective bargaining agreements in effect by the
Company and its Subsidiaries) (the “ERISA Documents”). The Company and its Subsidiaries are in
compliance with all applicable laws and regulations relating to labor, employment, fair employment
practices, terms and conditions of employment, and wages and hours, and with the terms of the ERISA
Documents; and each such ERISA Document is in compliance with all applicable requirements of ERISA,
except, in each case, where the failure to comply would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. To the Company’s knowledge, none of
the Company’s or its Subsidiaries’ employees are obligated under any contract (including licenses,
covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or
order of any court or administrative agency, that would interfere with the use of his or her
employment obligations to the Company or its Subsidiaries or that would conflict with the Company’s
and its Subsidiaries’ business as now conducted or proposed to be conducted, except for such
contracts and other agreements, judgments, decrees and orders that would not reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect.

     Section 2.17 No Brokers or Finders. No Person has or will have, as a result of the
transactions contemplated by this Agreement, any right, interest or claim against or upon the
Company, any of its Subsidiaries or any Purchaser for any commission, fee or other compensation as
a finder or broker because of any act or omission by the Company or any of its Subsidiaries, other
than Financial Technology Partners, LP whose fee is the sole responsibility of the Company.

     Section 2.18 Transactions with Affiliates. Except as disclosed in the Proxy
Statement, there were no loans, leases or other agreements, understandings or continuing
transactions between the Company or any of its Subsidiaries, on the one hand, and any officer or
director of the Company or any of its Subsidiaries or any Person that the Company believes is the
owner of five percent or more of the outstanding Common Stock and Nonvoting Common Stock in the
aggregate or any respective family member or Affiliate of such officer, director or stockholder,

-10-

 

on
the other hand, that were required by federal securities laws to be disclosed in the Proxy
Statement.

     Section 2.19 Insurance. The Company and each of its Subsidiaries maintains insurance
covering its properties, operations, personnel and businesses as the Company deems adequate. All
such insurance is fully in force, except where the failure to be in full force has not,
individually or in the aggregate, had, and would not reasonably be expected to have, a Material
Adverse Effect.

     Section 2.20 Investment Company Act. The Company is not, and immediately after giving
effect to the sale of the Purchased Shares and Warrants in accordance with this Agreement and the
application of the proceeds thereof will not be required to be registered as, an “investment
company” or a company “controlled” by an “investment company,” within the meaning of the Investment
Company Act.

     Section 2.21 Nasdaq. As of the date hereof, the Company’s Common Stock is listed on
the Nasdaq Global Select Market, and no event has occurred, and the Company is not aware of any
event that is reasonably likely to occur, that would result in the Common Stock being delisted from
the Nasdaq Global Select Market.

     Section 2.22 Delaware Section 203. The Board of Directors of the Company (or a
committee thereof), at a meeting duly called and held on May 29, 2008, has approved for purposes of
Section 203 of the Delaware General Corporation Law: (a) the sale and issuance of the Purchased
Shares and the Warrants to the Purchasers hereunder and the issuance of the Conversion Shares upon
conversion of the Purchased Shares and the issuance of the Warrant Shares upon exercise of the
Warrants; and (b) any transaction, including a purchase of Common Stock from any Person, in
compliance with Section 4.2(a) hereof in which either (or both) of the Purchasers become
“interested stockholders.”

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF EACH PURCHASER

     Each Purchaser, severally and not jointly, represents and warrants to the Company that:

     Section 3.1 Organization and Power. Such Purchaser is a limited partnership duly
formed, validly existing and in good standing under the laws of the jurisdiction of its formation
and has all requisite limited partnership power and authority to own its properties and to carry on
its business as presently conducted.

     Section 3.2 Authorization, Etc. Such Purchaser has all necessary limited partnership
power and authority, and has taken all necessary limited partnership action required for the due
authorization, execution, delivery and performance by such Purchaser of this Agreement and the
Related Agreements to which it is a party and the consummation by such Purchaser of the
transactions contemplated hereby and thereby. The authorization, execution, delivery and
performance by such Purchaser of this Agreement and the Related Agreements to which it is or will
be a party, and the consummation by such Purchaser of the transactions contemplated hereby and
thereby do not and will not: (a) violate or result in the breach of any provision of the
certificate of limited partnership and limited partnership agreement of such Purchaser; or (b)

-11-

 

with
such exceptions that, individually or in the aggregate, are not reasonably likely to have a
material adverse effect on its ability to perform its obligations under this Agreement and the
Related Agreements to which it is a party, whether after the giving of notice or the lapse of time
or both: (i) violate any provision of, constitute a breach of, or default under, or result in or
permit the cancellation, termination or acceleration of any material contract to which such
Purchaser is a party; or (ii) violate any provision of, constitute a breach of, or default under,
any applicable law. This Agreement has been, and each of the Related Agreements to which such
Purchaser will, at the Closing be party will be, duly executed and delivered by such Purchaser.
Assuming due execution and delivery thereof by the other Persons contemplated to be party thereto,
this Agreement and the Related Agreements will each be a valid and binding obligation of such
Purchaser enforceable against such Purchaser in accordance with its terms, except as such
enforceability may be limited by applicable laws relating to bankruptcy, insolvency,
reorganization, moratorium or other similar legal requirement relating to or affecting creditors’
rights generally and except as such enforceability is subject to general principles of equity
(regardless of whether enforceability is considered in a proceeding in equity or at law).

     Section 3.3 Government Approvals. No consent, approval, license or authorization of,
or designation, declaration or filing with, any court or governmental authority is or will be
required on the part of such Purchaser in connection with the execution, delivery and performance
by such Purchaser of this Agreement and the Related Agreements to which it is a party, except for:
(a) those which have already been made or granted; (b) the filing with the SEC of a Schedule 13D or
Schedule 13G and a Form 3 to report such Purchaser’s ownership of the Purchased Shares and
Warrants; (c) those where the failure to obtain such consent, approval or license would not have a
material adverse effect on the ability of the Purchasers to perform their obligations hereunder;
(d) in compliance with the provisions of the HSR Act in connection with any exercise of the
Warrants and (e) FSA Approval.

     Section 3.4 Investment Representations.

          (a) Such Purchaser is an “accredited investor” as that term is defined in Rule 501(a) of
Regulation D promulgated under the Securities Act.

          (b) Such Purchaser has been advised by the Company that neither the Purchased Shares nor the
Warrants have been registered under the Securities Act, that the Purchased Shares and the Warrants
will be issued on the basis of the statutory exemption provided by Section 4(2) under the
Securities Act or Regulation D promulgated thereunder, or
both, relating to transactions by an issuer not involving any public offering and under
similar exemptions under certain state securities laws, that this transaction has not been reviewed
by, passed on or submitted to any federal or state agency or self-regulatory organization where an
exemption is being relied upon, and that the Company’s reliance thereon is based in part upon the
representations made by such Purchaser in this Agreement and the Related Agreements. Such
Purchaser acknowledges that it has been informed by the Company of, or is otherwise familiar with,
the nature of the limitations imposed by the Securities Act and the rules and regulations
thereunder on the transfer of securities.

-12-

 

          (d) Such Purchaser is purchasing the Purchased Shares and the Warrants for its own account and
not with a view to, or for sale in connection with, any distribution thereof in violation of
federal or state securities laws.

          (e) By reason of its business or financial experience, such Purchaser has the capacity to
protect its own interest in connection with the transactions contemplated hereunder.

          (f) The Company has provided to such Purchaser all documents and information that such
Purchaser has requested relating to an investment in the Company. Such Purchaser recognizes that
investing in the Company involves substantial risks, and has taken full cognizance of and
understands all of the risk factors related to the acquisition of the Purchased Shares and the
Warrants. Such Purchaser has carefully considered and has, to the extent it believes such
discussion necessary, discussed with the Purchaser’s professional legal, tax and financial advisers
the suitability of an investment in the Company, and such Purchaser has determined that the
acquisition of the Purchased Shares and the Warrants is a suitable investment for the Purchaser.
Such Purchaser has not relied on the Company for any tax or legal advice in connection with the
purchase of the Purchased Shares or the Warrants. In evaluating the suitability of an investment in
the Company, such Purchaser has not relied upon any representations (other than the representations
and warranties of the Company set forth in Article II) or other information from the Company or any
of its agents, except for information made publicly available by the Company pursuant to filings
with the Securities and Exchange Commission, by press release or otherwise.

     Section 3.5 No Brokers or Finders. No Person has or will have, as a result of the
transactions contemplated by this Agreement, any right, interest or claim against or upon the
Company, any of its Subsidiaries or any Purchaser for any commission, fee or other compensation as
a finder or broker because of any act or omission by such Purchaser.

ARTICLE IV

COVENANTS OF THE PARTIES

     Section 4.1 Legends. Each Purchaser acknowledges and agrees that the Purchased Shares
and the Warrants will bear a legend in substantially the following form:

“The securities represented by this certificate have not been registered under the Securities
Act of 1933, as amended, and have been acquired for investment and not with a view to, or in
connection with, the sale or distribution thereof. Such shares may not be sold, offered for
sale, pledged or hypothecated in the absence of an effective registration statement
thereunder or an exemption from such registration.”

     Section 4.2 Restrictions on Actions.

          (a) Each Purchaser agrees that until the earlier of (i) the seventh anniversary of the date
of this Agreement, and the first anniversary of the date on which such Purchaser no longer owns any
Purchased Shares, Conversion Shares, Warrants or Warrant Shares (the “Restricted Period”), without
the prior written consent of the Company, it will not at any time, nor will it cause, suffer or
permit any of its Restricted Affiliates to agree to, make any public proposal to acquire or
acquire, directly or indirectly, by purchase or otherwise, record ownership

-13-

 

or beneficial ownership
(within the meaning of Rule 13d-3 under the Exchange Act ), of any securities of the Company which
if acquired would result in the Purchasers, in the aggregate, having record or beneficial ownership
of more than 19.9% of the outstanding shares of the Company’s Common Stock determined on a fully
diluted basis (which shall be determined assuming conversion of all of the shares of Series B
Preferred Stock, exercise of all Warrants for the full number of
Warrants Shares and conversion of all Nonvoting Common Stock);
provided, however, that if the Company takes any direct or indirect action that
results in the number of shares of Common Stock outstanding being reduced (e.g. stock repurchases),
no Purchaser shall be deemed to have breached this Section 4.2(a) as a result of such action.
The Company agrees that it shall not take any action, including the adoption or maintenance of a
shareholder rights plan, which would prohibit or restrict the Purchasers from purchasing securities
of the Company which purchases would be permitted by this Section 4.2(a).

          (b) During the Restricted Period without the prior written consent of the Company, the
Purchasers agree not to, directly or indirectly: (i) publicly propose to enter into, directly or
indirectly, any merger, consolidation, business combination or other similar transaction involving
the Company; (ii) make, or in any way participate in, any solicitation of proxies to vote any
securities of the Company under any circumstances for a change in the directors or management of
the Company, or in connection with a merger or acquisition of the Company, or deposit any
securities of the Company in a voting trust or subject them to a voting agreement or other
agreement of similar effect (it is understood and agreed that this clause (ii) shall not prohibit
any Purchaser from voting any securities of the Company in their discretion); (iii) form, join or
in any way participate in a “group” (within the meaning of Section 13(d)(3) of the Exchange Act)
with respect to any of securities of the Company that describes any plans or proposals required to
be disclosed in response to any of clauses (a) through (j) of Item 4 of any Schedule 13D (or any
amendment thereto), other than a group including solely the Purchasers and their Affiliates;
(iv) disclose any intention, plan or arrangement to change any of the members of the Board of
Directors, any of the executive officers of the Company or the certificate of incorporation or
bylaws of the Company, other than to the Company, directors of the Company, shareholders of the
Company that have a representative on the Board of Directors or the Purchasers’ representatives and
advisors; (v) publicly disclose any intention, plan or arrangement inconsistent with the foregoing,
or (vi) advise, assist or encourage any other Persons in connection with any of the foregoing; it
being understood that nothing in this Section 4.2(b)
shall restrict or prohibit the Series B Director or TCV Designee, or any other representative
of the Purchasers who is a director of the Company, from taking any action, or refraining from
taking any action, which he or she determines, in his or her sole discretion, is necessary to
fulfill his or her fiduciary duties as a member of the Board of Directors.

          (c) The provisions of Section 4.2(a) and (b) shall terminate in the event that the Board of
Directors shall: (i) approve a tender offer for a majority of the outstanding capital stock of the
Company; (ii) liquidate the Company or sell all or substantially all of the assets of the Company
to another Person; (iii) approve a merger or consolidation of the Company with any other Person
that would result in the voting securities of the Company outstanding immediately prior thereto
representing less than a majority of the voting power to elect a majority of the board of directors
or similar body of the Person surviving such merger or resulting from such consolidation; or (iv)
sell or otherwise issue to any Person voting securities of the Company that would result in such
Person having a majority of the combined voting

-14-

 

power of the voting securities of the Company. For
purposes hereof, “voting power” means the power to vote in the election of directors generally.

          (d) The provisions of Section 4.2(a) and (b) shall be reinstated and shall apply in full force
according to their terms in the event that: (i) if the provisions of Section 4.2(a) and (b) shall
have terminated as a result of a tender offer under clause (c)(i) above, such tender offer (as
originally made or as extended or modified) shall have terminated (without a majority of the
outstanding capital stock of the Company being accepted thereunder for purchase) prior to the
commencement of a tender offer by any Purchaser that would have been permitted pursuant to clause
(c)(i) as a result of such third-party tender offer; (ii) any tender offer by any Purchaser (as
originally made or as extended or modified) that was permitted to be made pursuant to clause
(c)(ii) through (iv) shall have terminated (without a majority of the outstanding capital stock of
the Company being accepted thereunder for purchase); or (iii) if the provisions of Section 4.2(a)
and (b) shall have terminated as a result of clause (c)(i), (iii) or (iv), the Board of Directors
shall have determined to rescind or abandon the previous action described in clause (c)(i) through
(iv) (and no such action shall have closed). Upon reinstatement of the provisions of Section
4.2(a) and (b), the preceding provisions of this Section 4.2 shall continue to govern, including,
without limitation, those that provide for the termination of any of the provisions of this Section
4.2 in the event that any of the events described in clause (c) shall occur.

     Section 4.3 Hedging Transactions.

     (a) Each Purchaser agrees that during the twelve months following the Closing it will not
enter into any Hedging Transactions.

     (b) If after the twelve month period referred to in Section 4.3(a), the Purchasers enter into
Hedging Transactions which at any one time collectively result in the Purchasers holding fewer than
1,750,000 (as adjusted for stock splits, stock reverse splits, dividends paid in shares of Common
Stock, combinations and the like with respect to the Common Stock) Economic Shares (a “Director
Suspension Event”), then the Purchasers shall send a notice to the Company stating that a Director
Suspension Event has occurred, and giving reasonable detail of the events giving rise to such
Director Suspension Event. If at any time after sending notice of a Director Suspension Event the
Hedging Transactions which gave rise to such Director Suspension Event
have terminated or expired, in whole or in part, or the Purchasers have entered into another
transaction, the result of which is that the Purchasers collectively hold 1,750,000 (as adjusted
for stock splits, stock reverse splits, dividends paid in shares of Common Stock, combinations and
the like with respect to the Common Stock) or more Economic Shares, then the Purchasers shall send
a notice to the Company stating that the Director Suspension Event has terminated, and providing
reasonable detail of the events giving rise to such termination, at which time the Director
Suspension Event shall terminate.

     (c) If after the twelve month period referred to in Section 4.3(a), the Purchasers enter
into Hedging Transactions which at any one time collectively result in the Purchasers holding fewer
than 1,050,000 (as adjusted for stock splits, stock reverse splits, dividends paid in shares of
Common Stock, combinations and the like with respect to the Common Stock) Economic Shares (a
“Protective Provision Suspension Event”), then the Purchasers shall send a notice to the Company
stating that a Protective Provision Suspension Event has occurred, and providing

-15-

 

reasonable detail
of the events giving rise to such Protective Provision Suspension Event. If at any time after
sending notice of a Protective Provision Suspension Event the Hedging Transactions which gave rise
to such Protective Provision Suspension Event have terminated or expired, in whole or in part, or
the Purchasers have entered into other transactions, the result of which is that the Purchasers
collectively hold 1,050,000 (as adjusted for stock splits, stock reverse splits, dividends paid in
shares of Common Stock, combinations and the like with respect to the Common Stock) or more
Economic Shares, then the Purchasers shall send a notice to the Company stating that the Protective
Provision Suspension Event has terminated, and providing reasonable detail of the events giving
rise to such termination, at which time the Protective Provision Suspension Event shall terminate.

     Section 4.4 TCV Director.

     (a) For so long as the Purchasers, as holders of Series B Preferred Stock, have the right to
elect a director pursuant to the terms of the certificate of designation for the Series B Preferred
Stock (the “Series B Director”), the Purchasers agree not to elect any Person as a Series B
Director who has not been approved by a majority of the Company’s Independent Directors, which
approval shall not be unreasonably withheld or delayed. In addition, the Purchasers agree not to
elect any Person as a Series B Director until the Purchasers have received the FSA Approval.

     (b) At any time after receipt of the FSA Approval and  prior to the date on which the Purchasers no longer own any
Purchased Shares, Conversion Shares, Warrants or Warrant Shares, if the Purchasers are not entitled to elect a
Series B Director pursuant to the terms of the certificate of designation for the Series B
Preferred Stock, then for so long as, the Purchasers beneficially own at
least 1,750,000 shares (as adjusted for stock splits, stock reverse splits, dividends paid in
shares of Common Stock, combinations and the like with respect to the Common Stock) of Common Stock
(excluding shares of Common Stock issuable upon exercise of the Warrants), the Purchasers shall
have the right to nominate one (1) member of the Board of Directors (the “TCV Designee”). Subject
to the prior approval of a majority of the Independent Directors, which approval shall not be
unreasonably withheld or delayed, the Board of Directors shall promptly elect the TCV Designee to
the Board of Directors. In the event that a TCV Designee is not approved by the Independent
Directors, then the Purchasers shall have the right to substitute
other TCV Designees until one is so approved. If, following election to the Board of
Directors, the TCV Designee resigns, is removed, is not re-elected or is otherwise unable to serve
for any reason, then, the Purchasers shall be entitled to designate a replacement nominee, who
shall become the TCV Designee, and subject to the approval provided for in this Section 4.4(b) by
the majority of the Independent Directors, shall be elected by the Board of Directors.

     (c) Upon receipt by the Company of a notice of a Director Suspension Event, (x) in the event
the Purchasers are entitled pursuant to the certificate of designation for the Series B Preferred
Stock to elect a Series B Director, and a Series B Director has been so elected, the Purchasers, at
the request of the Board of Directors, shall remove such Series B Director, and (y) in the event
the Purchasers are not so entitled to elect a Series B Director, but have pursuant to Section
4.4(b) above nominated and had elected a TCV Designee, the Purchasers shall, at the request of the
Board of Directors, use its reasonable efforts to have such TCV Designee resign as a director.
Upon the termination of the Director Suspension Event, (i) in the event the

-16-

 

Purchasers are entitled
pursuant to the certificate of designation for the Series B Preferred Stock to elect a Series B
Directors, the Purchasers may then again, subject to the approval of a majority of the Independent
Directors provided for in Section 4.4(a), elect a Series B Director, and (ii) if a TCV Designee
resigned pursuant to clause (y) of this Section 4.4(c), then at the request of the Purchasers, the
Board of Directors shall re-elect the TCV Designee to the Board of Directors.

     (d) The Company shall (i) upon a TCV Designee becoming a director of the Company enter into
an indemnification agreement with such TCV Designee in the form entered into with the other
directors of the Company, and (ii) cause the TCV Designee to be covered by any directors and
officers insurance policy maintained by the Company from time to time at all times that a TCV
Designee serves on the Board of Directors.

     Section 4.5 Rights Agreement. In the event that the Company adopts, enters into or
maintains a shareholder rights plan, the primary purpose of which is to prevent an acquisition of
the Company in a transaction not approved by Board of Directors (a “Shareholder Rights Plan”) the
Company agrees that such Shareholder Rights Plan shall (i) ensure that the shares of Common Stock
issued upon conversion of the Series B Preferred Stock or the exercise of the Warrant shall be
entitled to receive any preferred stock purchase right or any other benefit or right granted
to shares of Common Stock, (ii) not prevent, prohibit or restrict TCV and its Affiliates (including
by treating them as an “acquiring person” under the Shareholder Rights Plan), (x) from acquiring,
directly or indirectly, by purchase or otherwise, record ownership or beneficial ownership (within
the meaning of Rule 13d-3 under the Exchange Act ), of any securities of the Company which if
acquired would result in the Purchasers and their Affiliates, in the aggregate, having record or
beneficial ownership of more than 19.9% of the outstanding shares of the Company’s Common Stock
determined on a fully diluted basis (which shall be determined assuming conversion of all of the
shares of Series B Preferred Stock and exercise of all Warrants for the full number of Warrants
Shares), and (y) from continuing to own, beneficially and of record, any securities of the Company
if the Company takes any direct or indirect action that results in the number of shares of Common
Stock determined on a fully diluted basis being reduced (e.g. stock repurchases).

     Section 4.6 Specific Performance. The Purchasers and the Company agree that
irreparable damage would occur and that the Company
and the Purchaser, as applicable, would not have any adequate remedy at law in the event that
any of the provisions of Sections 4.2, (Restrictions on Actions), 4.3 (Hedging Transactions), 4.4
(TCV Director) or 4.5 (Rights Agreement) were not performed in accordance with their specific terms
or were otherwise breached. Accordingly, the Purchasers and the Company agree that the Company and
the Purchasers, as applicable, shall without the necessity of proving the inadequacy of money
damages or posting a bond be entitled to an injunction or injunctions to prevent breaches of such
Sections and to enforce specifically the terms, provisions and covenants contained therein, this
being in addition to any other remedy to which they are entitled at law or in equity.

-17-

 

ARTICLE V

CONDITIONS TO THE PURCHASERS’ OBLIGATION

     Section 5.1 Initial Closing. The obligations of the Purchasers to consummate the
transactions contemplated hereby to be consummated at the Initial Closing are subject to the
satisfaction, on or prior to the Initial Closing Date, of each of the following conditions
precedent:

          (a) Representations and Warranties. Each of the representations and warranties of the
Company contained in Article II of this Agreement shall be true and correct in all material
respects on and as of the Initial Closing Date with the same effect as though such representations
and warranties had been made on and as of the Initial Closing Date, except for representations and
warranties that speak as of a specific date or time other than the Initial Closing Date (which need
only be true and correct in all material respects as of such date or time); provided,
however, that if a representation or warranty is qualified by “materiality” or “Material
Adverse Effect” or similar qualifier, such representation or warranty (as so qualified) shall be
true and correct in all respects.

          (b) Covenants. The Company shall have performed and complied in all material respects
with all other covenants and agreements required by this Agreement to be performed or complied with
by it at or prior to the Initial Closing.

          (c) Certificates. The Company shall have delivered to the Purchasers (i) a
certificate, dated as of the Initial Closing Date and executed on behalf of the Company by its
Chief Executive Officer, to the effect that each of the conditions set forth in clauses (a) and (b)
of this Section 5.1 has been satisfied, and (ii) a certificate, dated as of the Initial Closing
Date and executed on behalf of the Company by its Secretary, certifying the Company’s (A) amended
and restated certificate of incorporation, (B) bylaws, as amended, and (C) board resolutions
approving this Agreement, the Related Agreements and the transactions contemplated hereby and
thereby.

          (d) Series B Preferred Stock Certificates. The Company shall have delivered one or
more stock certificates to
each Purchaser representing the portion of the Purchased Shares to be purchased by such
Purchaser at the Initial Closing.

          (e) Investor Rights Agreement. The Company shall have entered into the Investor
Rights Agreement.

          (f) Legal Opinion. The Company shall have provided an opinion addressed to the
Purchasers rendered by its outside legal counsel in form and substance reasonably satisfactory to
the Purchasers, in substantially the form attached hereto as Exhibit D with respect to the
Purchased Shares and Warrants to be purchased at the Initial Closing.

          (g) Certificate of Designation. The Certificate of Designation shall have been duly
filed with the Secretary of State of the State of Delaware.

          (h) Warrants. The Company shall have entered into and delivered the Warrants to the
Purchasers that are to be purchased by the Purchasers at the Initial Closing.

-18-

 

     Section 5.2 Subsequent Closing. The obligations of the Purchasers to consummate the
transactions contemplated hereby to be consummated at the Subsequent Closing are subject to the
satisfaction, on or prior to the Subsequent Closing Date, of each of the following conditions
precedent:

          (a) Initial Closing. The transactions contemplated to occur at the Initial Closing
shall have been consummated.

          (b) FSA Approval. To the extent required, the Purchasers shall have received FSA
Approval.

          (c) Representations and Warranties. Each of the representations and warranties of the
Company contained in Article II of this Agreement shall be true and correct in all material
respects on and as of the Subsequent Closing Date with the same effect as though such
representations and warranties had been made on and as of the Subsequent Closing Date, except for
representations and warranties that speak as of a specific date or time other than the Subsequent
Closing Date (which need only be true and correct in all material respects as of such date or
time); provided, however, that if a representation or warranty is qualified by
“materiality” or “Material Adverse Effect” or similar qualifier, such representation or warranty
(as so qualified) shall be true and correct in all respects.

          (d) Covenants. The Company shall have performed and complied in all material respects
with all other covenants and agreements required by this Agreement to be performed or complied with
by it at, or prior to, the Subsequent Closing.

          (e) Certificates. The Company shall have delivered to the Purchasers a certificate,
dated as of the Subsequent Closing Date and executed on behalf of the Company by its Chief
Executive Officer, to the effect that each of the conditions set forth in clauses (c) and (d) of
this Section 5.2 has been satisfied.

          (f) Series B Preferred Stock Certificates. The Company shall have delivered one or
more stock certificates to each Purchaser representing the portion of the Purchased Shares to be
purchased by such Purchaser at the Subsequent Closing.

          (g) Legal Opinion. The Company shall have provided an opinion addressed to the
Purchasers rendered by its outside legal counsel in form and substance reasonably satisfactory to
the Purchasers, in substantially the form attached hereto as Exhibit D with respect to the
Purchased Shares and Warrants to be purchased at the Subsequent Closing.

          (h) Warrants. The Company shall have entered into and delivered the Warrants to the
Purchasers that are to be purchased by the Purchasers at the Subsequent Closing.

-19-

 

ARTICLE VI

CONDITIONS TO THE COMPANY’S OBLIGATION

     Section 6.1. Initial Closing. The obligations of the Company to consummate the
transactions contemplated hereby are subject to the satisfaction, on or prior to the Initial
Closing Date, of each of the following conditions precedent:

          (a) Representations and Warranties; Performance. Each of the representations and
warranties of the Purchasers contained in Article III of this Agreement shall be true and correct
in all material respects on and as of the Initial Closing Date with the same effect as though such
representations and warranties had been made on and as of the Initial Closing Date, except for
representations and warranties that speak as of a specific date or time other than the Initial
Closing Date (which need only be true and correct in all material respects as of such date or
time); provided, however, that if a representation or warranty is qualified by
“materiality” or “material adverse effect” or similar qualifier, such representation or warranty
(as so qualified) shall be true and correct in all respects.

          (b) Covenants. The Purchasers shall have performed and complied in all material
respects with all other covenants and agreements required by this Agreement to be performed or
complied with by them at or prior to the Initial Closing.

          (c) Certificates. The Purchasers shall have delivered to the Company a certificate,
dated as of the Initial Closing Date and
executed on behalf of the Purchasers by their authorized representative, to the effect that
each of the conditions set forth in clauses (a) and (b) of this Section 6.1 has been satisfied.

          (d) Consideration for the Securities. Each Purchaser shall have paid the purchase
price of the Purchased Shares and Warrants to be purchased by such Purchaser in full at the Initial
Closing either by certified check or by wire transfer of immediately available funds to an account
designated in writing by the Company.

          (e) Investor Rights Agreement. The Purchasers shall have entered into the Investor
Rights Agreement.

          (f) Certificate of Designation. The Certificate of Designation shall have been duly
filed with the Secretary of State of the State of Delaware.

          (g) Warrants. The Purchasers shall have entered into and delivered the Warrants to
the Company that are to be purchased by the Purchasers at the Initial Closing.

     Section 6.2. Subsequent Closing. The obligations of the Company to consummate the
transactions contemplated hereby are subject to the satisfaction, on or prior to the Subsequent
Closing Date, of each of the following conditions precedent:

          (a) Initial Closing. The transactions contemplated to occur at the Initial Closing
shall have been consummated.

-20-

 

          (b) FSA Approval. To the extent required, the Purchasers shall have received FSA
Approval.

          (c) Representations and Warranties; Performance. Each of the representations and
warranties of the Purchasers contained in Article III of this Agreement shall be true and correct
in all material respects on and as of the Subsequent Closing Date with the same effect as though
such representations and warranties had been made on and as of the Subsequent Closing Date, except
for representations and warranties that speak as of a specific date or time other than the
Subsequent Closing Date (which need only be true and correct in all material respects as of such
date or time); provided, however, that if a representation or warranty is qualified
by “materiality” or “material adverse effect” or similar qualifier, such representation or warranty
(as so qualified) shall be true and correct in all respects.

          (d) Covenants. The Purchasers shall have performed and complied in all material
respects with all other covenants and agreements required by this Agreement to be performed or
complied with by them at or prior to the Subsequent Closing.

          (e) Certificates. The Purchasers shall have delivered to the Company a certificate,
dated as of the Subsequent Closing Date and
executed on behalf of the Purchasers by their authorized representative, to the effect that
each of the conditions set forth in clauses (c) and (d) of this Section 6.2 has been satisfied.

          (f) Consideration for the Securities. Each Purchaser shall have paid the purchase
price of the Purchased Shares and Warrants to be purchased by such Purchaser in full at the
Subsequent Closing either by certified check or by wire transfer of immediately available funds to
an account designated in writing by the Company.

          (g) Warrants. The Purchasers shall have entered into and delivered the Warrants to
the Company that are to be purchased by the Purchasers at the Subsequent Closing

ARTICLE VII

MISCELLANEOUS

     Section 7.1 Survival of Representations. The representations, warranties, covenants
and agreements made herein or in any certificates or documents executed in connection herewith
shall survive the execution and delivery hereof and the Closing of the transactions contemplated
hereby. Notwithstanding the foregoing, the representations and warranties contained in or made
pursuant to this Agreement shall terminate on, and no claim or action with respect thereto may be
brought with respect to such representation and warranties after the date that is 12 months after
the Closing; except for the representations and warranties set forth in Sections 2.2, 2.17 and 2.22
which shall survive indefinitely.

     Section 7.2 Shares Owned by Affiliates. For the purposes of applying all provisions
of this Agreement which condition the receipt of information or access to information or exercise
of any rights upon ownership of a specified number or percentage of shares, the shares owned of
record by any Affiliate of a Purchaser shall be deemed to be owned by such Purchaser.

-21-

 

     Section 7.3 Counterparts. This Agreement may be executed in one or more counterparts,
all of which shall be considered one and the same agreement, and will become effective when one or
more counterparts have been signed by a party and delivered to the other parties. Copies of
executed counterparts transmitted by telecopy, telefax or other electronic transmission service
shall be considered original executed counterparts for purposes of this Section 7.3, provided that
receipt of copies of such counterparts is confirmed.

     Section 7.4 Governing Law.

          (a) Except to the extent the DGCL is mandatorily applicable, this Agreement and any disputes
arising hereunder or controversies related hereto shall be governed by and construed in accordance
with the internal laws of the State of New York that apply to contracts made and performed entirely
within such state.

          (b) Each of the parties hereto irrevocably (i) submit to the exclusive jurisdiction of any
court of the State of New York located in New York County or the United States District Court for
the Southern District of New York for the purpose of any suit, action, or other proceeding arising
out of this Agreement or the Related Agreements (each a “Proceeding”), (ii) agree that service of
any process, summons, notice or document in accordance with Section 7.7 hereof shall be effective
service of process for any Proceeding brought against such party; (iii) irrevocably and
unconditionally waive any objection to the laying of venue of any Proceeding arising out of or
relating to this Agreement in any such court; (iv) agree that all claims in respect of any
Proceeding may be heard and determined in any such court; and (v) agree not to commence any
Proceeding other than in such court, and waive, to the fullest extent permitted by applicable law,
any claim that any such Proceeding is brought in an inconvenient forum.

          (c) To the extent that any party hereto has or hereafter may acquire any immunity from
jurisdiction of any court or from any legal process (whether through service or notice, attachment
prior to judgment, attachment in aid of execution, execution or otherwise) with respect to itself,
or to such Person’s property, each such party hereto hereby irrevocably waives such immunity in
respect of such Person’s obligations with respect to this Agreement.

          (d) Waiver of Jury Trial. EACH PARTY HERETO, FOR ITSELF AND ITS AFFILIATES, HEREBY
IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ALL RIGHT
TO TRIAL BY JURY IN ANY ACTION, SUIT OR OTHER PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR
OTHERWISE) ARISING OUT OF OR RELATING TO THE ACTIONS OF THE PARTIES HERETO OR THEIR RESPECTIVE
AFFILIATES PURSUANT TO THIS AGREEMENT OR IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE OR
ENFORCEMENT HEREOF.

     Section 7.5	Entire Agreement; No Third Party Beneficiary.  This Agreement and the
Related Agreements contain the entire agreement by and among the parties with respect to the
subject matter hereof and all prior negotiations, writings and understandings relating to the
subject matter of this Agreement, including the letter of intent dated May 23, 2008 between the
Company and TCV VI, are merged in and are superseded and canceled by, this Agreement and
the Related Agreements.  Notwithstanding anything to the contrary in the foregoing, the
Confidentiality Agreement dated May 27, 2008

-22-

 

between the Company and TCMI, Inc. shall,
notwithstanding clause (ii) of paragraph 16 thereof, continue in effect in accordance with its
terms with respect to the provisions thereof related to Evaluation Material (as defined therein),
 including, without limitation, Sections 1 through 6 thereof and related provisions.  Except with
respect to Section 4.4(d), this Agreement is not intended to confer upon any Person not a party
hereto (or their successors and permitted assigns) any rights or remedies hereunder.

     Section 7.6 Expenses. All fees, costs and expenses incurred in connection with this
Agreement and the transactions contemplated hereby, including accounting and legal fees shall be
paid by the party incurring such expenses, except that, upon consummation of the Initial Closing,
the Company shall pay up to $150,000 of the reasonable and documented out-of-pocket fees and
expenses incurred by the Purchasers, including, without limitation, the reasonable and documented
fees and expenses of counsel for the Purchasers.

     Section 7.7 Notices. All notices and other communications hereunder will be in
writing and given by certified or registered mail, return receipt requested, nationally recognized
overnight delivery service, such as Federal Express or facsimile (or like transmission) with
confirmation of transmission by the transmitting equipment or personal delivery against receipt to
the party to whom it is given, in each case, at such party’s address or facsimile number set forth
below or such other address or facsimile number as such party may hereafter specify by notice to
the other parties hereto given in accordance herewith. Any such notice or other communication
shall be deemed to have been given as of the date so personally delivered or transmitted by
facsimile or like transmission, on the next business day when sent by overnight delivery services
or five days after the date so mailed if by certified or registered mail.

If to the Company, to:

MarketAxess Holdings Inc.

140 Broadway, 42nd Floor

New York, NY 10005

Fax No.: (212) 813-6390

Attention: Chief Executive Officer

with a copy to:

Proskauer Rose LLP

1585 Broadway

New York, NY 10036

Attention: Adam J. Kansler

-23-

 

If to a Purchaser, to:

Technology Crossover Ventures

528 Ramona Street

Palo Alto, CA 94301

Fax No.: (650) 614-8222

Attention: Carla S. Newell

with a copy to:

Latham & Watkins LLP

140 Scott Drive

Menlo Park, CA 94025

Fax No.: (650) 463-2600

Attention: Peter F. Kerman

     Section 7.8 Successors and Assigns. This Agreement will be binding upon and inure to
the benefit of the parties hereto and their
respective successors and permitted assigns. Any purported assignment or delegation in
violation of this Agreement shall be null and void ab initio.

     Section 7.9 Headings. The Section, Article and other headings contained in this
Agreement are inserted for convenience of reference only and will not affect the meaning or
interpretation of this Agreement.

     Section 7.10 Amendments and Waivers. This Agreement may not be modified or amended
except by an instrument or instruments in writing signed by each party hereto. Any party hereto
may, only by an instrument in writing, waive compliance by any other party or parties hereto with
any term or provision hereof on the part of such other party or parties hereto to be performed or
complied with. No failure or delay of any party in exercising any right or remedy hereunder shall
operate as a waiver thereof, nor will any single or partial exercise of any right or power, or any
abandonment or discontinuance of steps to enforce such right or power, preclude any other or
further exercise thereof or the exercise of any other right or power. The waiver by any party
hereto of a breach of any term or provision hereof shall not be construed as a waiver of any
subsequent breach. The rights and remedies of the parties hereunder are cumulative and are not
exclusive of any rights or remedies that they would otherwise have hereunder.

     Section 7.11 Interpretation; Absence of Presumption.

          (a) For the purposes hereof: (i) words in the singular shall be held to include the plural
and vice versa and words of one gender shall be held to include the other gender as the context
requires; (ii) the terms “hereof,” “herein,” and “herewith” and words of similar import shall,
unless otherwise stated, be construed to refer to this Agreement as a whole (including all of the
Schedules and Exhibits) and not to any particular provision of this Agreement, and Article,
Section, paragraph, Exhibit and Schedule references are to the Articles, Sections, paragraphs,
Exhibits, and Schedules to this Agreement unless otherwise specified; (iii) the word “including”
and words of similar import when used in this Agreement shall mean “including, without

-24-

 

limitation,”
unless the context otherwise requires or unless otherwise specified; and (iv) the word “or” shall
not be exclusive.

          (b) With regard to each and every term and condition of this Agreement and any and all
agreements and instruments subject to the terms hereof, the parties hereto understand and agree
that the same have or has been mutually negotiated, prepared and drafted, and if at any time the
parties hereto desire or are required to interpret or construe any such term or condition or any
agreement or instrument subject hereto, no consideration will be given to the issue of which party
hereto actually prepared, drafted or requested any term or condition of this Agreement or any
agreement or instrument subject hereto.

     Section 7.12 Severability. Any provision hereof that is held to be invalid, illegal
or unenforceable in any respect by a court of competent jurisdiction, shall be ineffective only to
the extent of such invalidity, illegality or unenforceability, without affecting in any way the
remaining provisions hereof, provided, however, that the parties will attempt in
good faith to reform this Agreement in a manner consistent with the intent of any such ineffective
provision for the purpose of carrying out such intent.

[The next page is the signature page]

-25-

 

     The parties have caused this Securities Purchase Agreement to be executed as of the date first
written above.

	 	 	 	 	 
	 	 	MARKETAXESS HOLDINGS INC.
	 
	 	 	 	 
	 

	 	By:	 	/s/ Richard M. McVey
	 

	 	 	 	 
	     

	 	 	 	Name: Richard M. McVey
	    

	 	 	 	 Title: Chief Executive Officer
	 
	 	 	 	 
	 	 	TCV VI, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	Technology Crossover Management VI,
L.L.C.
	 

	 	Its:
	 	General Partner
	 
	 	 	 	 
	 

	 	By:	 	/s/ Carla S. Newell
	 

	 	 	 	 
	 

	 	   
	 	   Name: Carla S. Newell
	 

	 	   
	 	   Title: Attorney-in-Fact
	 
	 	 	 	 
	 	 	TCV MEMBER FUND, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	Technology Crossover Management VI,
L.L.C.
	 

	 	Its:
	 	General Partner
	 
	 	 	 	 
	 

	 	By:	 	/s/ Carla S. Newell
	 

	 	 	 	 
	 

	 	   
	 	   Name: Carla S. Newell
	 

	 	   
	 	   Title: Attorney-in-Fact

S-1 

 

EXHIBIT A

DEFINED TERMS

     1. The following capitalized terms have the meanings indicated:

     “Affiliate” of any Person means any Person, directly or indirectly, controlling, controlled by
or under common control with such Person.

     “Board of Directors” means the Company’s board of directors.

     “Code” means the Internal Revenue Code of 1986, as amended.

     “Common Stock” means the Company’s voting common stock, $0.003 par value per share.

     “DGCL” means the Delaware General Corporation Law.

     “Economic Shares” means with respect to the Purchasers the aggregate, without duplication, of
(i) shares of Common Stock beneficially owned by the Purchasers (excluding shares issuable upon
exercise of the Warrants until such time as the shares are issued upon exercise), plus (ii) shares
of Common Stock issuable upon shares of Series B Preferred Stock beneficially owned by the
Purchasers, less (iii) shares of Common Stock that are the subject of Hedging Transactions.

     “ERISA” means the Employee Retirement Income Security Act of 1974, as amended.

     “Exchange Act” means the Securities Exchange Act of 1934, as amended.

     “FINRA” means the Financial Industry Regulatory Authority.

     “FSA” means the Financial Services Authority.

     “FSA Approval” means the approval by the FSA of the Purchasers and their relevant Affiliates
acquiring “control” of MarketAxess Europe Limited pursuant to the transactions contemplated by the
Agreement and the Related Agreements, where “control” has the meaning given to it in the FSA Rules.

     “FSA Rules” means the rules, requirements, guidance and directions issued by the FSA.

     “GAAP” means generally accepted accounting principles as in effect in the United States.

     “Hedging Transactions” means the entering (i) into a Short Sale, (ii) into or establishment of
any agreement constituting a “put equivalent position,” as defined by Rule 16a-1(h) of the Exchange
Act, or (iii) otherwise entering into a hedging transaction the primary purpose of which is to
offset the loss which results from a decline in the market price of the Common Stock.

A-1 

 

     “HSR Act” means the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended, and rules and regulations promulgated thereunder.

     “Independent Director” shall mean the directors of the Company which the Company’s board of
directors has determined are “independent” within the meaning of Rule 4200(a)(15) of NASDAQ.

     “Intellectual Property Rights” means all registered copyrights, copyright registrations and
copyright applications, trademark registrations and applications for registration, patents and
patent applications, trademarks, service marks, trade names and Internet domain names that are used
by the Company or any of its Subsidiaries in their business as presently conducted, including all
(i) databases, computer programs and other computer software user interfaces, know-how, trade
secrets, customer lists, proprietary technology, processes and formulae, source code, object code,
algorithms, development tools, instructions and templates created by or on behalf of the Company or
any of its Subsidiaries and (ii) inventions, trade dress, logos and designs created by or on behalf
or any of the Company or any of its Subsidiaries.

     “Investment Company Act” mean the Investment Company Act of 1940, as amended.

     “Investor Rights Agreement” means the Investor Rights Agreement among the Company and each of
the Purchasers in the form attached to the Agreement as Exhibit C.

     “Lien” means any mortgage, pledge, security interest or other encumbrance, excluding
(A) statutory liens for Taxes that are not yet due and payable; (B) statutory liens to secure
obligations to landlords, lessors or renters under leases or rental agreements; (C) deposits or
pledges made in connection with, or to secure payment of, workers’ compensation, unemployment
insurance or similar programs mandated by applicable law; (D) statutory liens in favor of carriers,
warehousemen, mechanics and materialmen, to secure claims for labor, materials or supplies and
other like liens; and (E) encumbrances pursuant to securities laws.

     “Material Adverse Effect” means a material adverse effect upon the business, financial
condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken
as a whole.

     “Person” means an individual, corporation, partnership, limited liability company, joint
venture, trust or unincorporated organization or a government or agency or political subdivision
thereof.

     “Proxy Statement” means the Company’s definitive proxy statement for its 2008 annual meeting
of stockholders, as filed with the SEC on April 23, 2008.

     “Restricted Affiliate” means: (a) any Person who is directly or indirectly responsible for the
formation, management, operations, oversight or administration of the Purchasers (including,
without limitation, any principals, partners or employees of any such Person); and (b) any
investment fund directly or indirectly formed, managed or controlled by any one or more Persons
referred to in the preceding clause (a).

     “SEC” means the United States Securities and Exchange Commission.

A-2 

 

     “SEC Documents” means all reports, schedules, registration statements, proxy statements and
other documents (including all amendments, exhibits and schedules thereto) filed by the Company
with the SEC on or after January 1, 2006.

     “Short Sale” means a sale of Common Stock that is marked as a short sale.

     “Stock Plans” means the Company’s 2000 Stock Incentive Plan, the Company’s 2001 Stock
Incentive Plan and the Company’s 2004 Stock Incentive Plan, as each has been amended to the date
hereof.

     “Subsidiary” means, when used with reference to a party, any corporation or other
organization, whether incorporated or unincorporated, of which such party or any other Subsidiary
of such party is a general partner (excluding partnerships the general partnership interests of
which held by such party or any Subsidiary of such party do not have a majority of the voting
interests in such partnership) or serves in a similar capacity, or, with respect to such
corporation or other organization, at least a majority of the securities or other interests having
by their terms ordinary voting power to elect a majority of the board of directors or others
performing similar functions is directly or indirectly owned or controlled by such party or by any
one or more of its Subsidiaries, or by such party and one or more of its Subsidiaries.

     “Tax” and “Taxes” means all federal, state, local and foreign taxes, including, without
limitation, income, franchise, property, sales, withholding, payroll and employment taxes.

A-3 

 

	 	2.	 	The following terms are defined in the Sections of the Agreement indicated:

INDEX OF TERMS

	 	 	 	 	 
	Term	 	Section	 
	Agreement
	 	Preamble
	Certificate of Designation
	 	 	1.1	 
	Company
	 	Preamble
	Conversion Shares
	 	 	2.4	(b)
	ERISA Documents
	 	 	2.16	 
	Financial Statements
	 	 	2.7	 
	Initial Closing
	 	 	1.2	 
	Initial Closing Date
	 	 	1.2	 
	Preferred Stock
	 	 	2.4	(a)
	Purchased Shares
	 	Recitals
	Purchasers
	 	Preamble
	Related Agreements
	 	 	2.2	 
	Restricted Period
	 	 	4.2	 
	Securities Act
	 	 	2.4	(c)
	Series B Preferred Stock
	 	Recitals
	Subsequent Closing
	 	1.2
	Subsequent Closing
Date
	 	1.2
	TCV Member Fund
	 	Preamble
	TCV VI
	 	Preamble
	Warrant Shares
	 	Recitals
	Warrants
	 	Recitals

A-4 

 

SCHEDULE 1.1

PURCHASED SHARES AND WARRANT SHARES

	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Number	 	 	 	 
	 	 	Number of	 	 	of	 	 	 	 
	 	 	Purchased	 	 	Warrant	 	 	Aggregate	 
	Purchaser	 	Shares	 	 	Shares	 	 	Purchase Price	 
	TCV VI, L.P.
	 	 	 	 	 	 	 	 	 	 	 	 
	Initial Closing
	 	 	27,781.220786	 	 	 	555,624	 	 		27,781,220.79	 
	Subsequent Closing
	 	 	6,945.305197	 	 	 	138,906	 	 		6,945,305.20	 
	Total
	 	 	34,726.525983	 	 	 	694,530	 	 	$	34,726,525.99	 
	 
	 	 	 	 	 	 	 	 	 
	 
	TCV Member Fund, L.P.
	 	 	 	 	 	 	 	 	 	 	 	 
	Initial Closing
	 	 	218.779214	 	 	 	4,376	 	 		218,779.21	 
	Subsequent Closing
	 	 	54.694803	 	 	 	1,094	 	 		54,694.80	 
	Total
	 	 	273.474017	 	 	 	5,470	 	 	$	273,474.01	 
	 
	 	 	 	 	 	 	 	 	 
	 
	Total
	 	 	35,000.000000	 	 	 	700,000	 	 	$	35,000,000.00

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}]]